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I. General introduction - Diarylethenes for Photochromism 
 
I.1 History 
 
Probably, Alexander the Great (356 – 323 B. C.) used already colour changes 
of a photochromic dye to coordinate his troop attacks.1 His macedonian warriors 
used wristbands treated with an unknown photochromic dye. Upon appropriate 
irradiation of the sunlight colour changes occurred, telling the troops the right 
time of attack.2 
 
The term photochromism was introduced by Hirshberg in 1950.3 However, 
TerMeer described this effect already in the year 1876. Since then 
photochromism was observed in a couple of organic and inorganic compounds. 
 
 
I.2 Photochromic Molecular Switches  
 
Molecular switches are defined as compounds that can be toggled between two 
isomers A and B (Figure 11) by an external stimulus.5 Each isomer shows 
particular properties such as absorption spectra and emission. The used stimuli 
that trigger the toggling of the compound can be light, heat, electrons, and 
chemical reagents. Photochromism is described by the reversible conversion 
between two isomers having different absorption spectra. Therefore, the 
electrocyclization (switching) process can be followed by UV-VIS absorption 
spectroscopy. An example of the absorption spectra of a typical isomerization 
process between isomers A and B is shown in Figure 1. As isomer A is 
irradiated in the UV region (hν1), a new band is generated in the visible region 
as isomer B is originated. Cyclization back to A is accomplished by irradiating B 
with visible light (hν2). During the isomerization process an isosbestic points 
should evolve to indicate that the photoisomerization is a clean process that 
means without degradation or formation of side products takes place. 
Separated absorption maxima allow addressing each isomer independently. 
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Irradiation with the appropriate wavelength will only affect one isomer. For 
example, if both isomers absorb within the energy range hν1, stimulation of 
isomerisation of A -> B and B -> A can result. The transfer to the ring-closed 
isomer B is not complete; instead, A (ring-open) and B (ring-closed) are in a 
equilibrium (called the photostationary state).6 
 
 
Figure 1.  UV-Vis absorption spectra of a typical photoisomerization reaction 
between differently coloured isomers A and B.6  
 
The ability to control the physical properties of molecular switches makes them 
appealing candidates for the use in a range of applications such as filters, 
sensors, information storage and medicinal chemistry. In particular, eyewears 
varying between dark and light lenses in response to changing light conditions 
are constructed from photoresponsive compounds or they are used to control 
biological systems by external stimuli. It has to be taken into account that 
according to the application, several specific properties are often necessary. For 
example, it is critical that a given system is able to interconvert between its 
isomers many times without significant degradation (fatigue resistance), which 
is important for the use as a device. Also, it is desirable that the photostationary 
 12
state is quantitative. It is also considered desirable for photoresponsive 
compounds to exhibit thermal stability of each form (bistability).6, 7 
During the photoisomerization process sigma and pi bonds are formed or 
broken. If the isomerization process involves aromatic pi systems that are 
present in one isomer and destroyed in the other, a driving force for the thermal 
back reaction is created (as defined by the aromatic stabilization energy). From 
the different aromatic and heteroaromatic systems shown in Figure 2, thiophene 
having the smallest aromatic stabilization energy leads to the most thermally 
stable photochromic diarylethenes. 
 13
group  energy (kcal/mol) 
 
phenyl                              27.7   
pyrrolyl          13.8 
furyl                       9.1 
thienyl                      4.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.       Aromatic stabilization energies of different aryls.4  
 
 
I.3 Light as a Stimulus7 
 
Photons are a suitable stimulus for isomerization because modern lasers can 
be used to achieve fast response times and focus a fine-tuned light stimulus of 
a specific wavelength on small localized areas, e.g. in a film, without significant 
diffusion.8 The alternations in the electronic structure of the molecules that are 
responsible for the dramatic changes in colour can also result in variations of 
other useful physical properties such as luminescence,9 electrical 
conductance,10 refractive index,11 optical rotation12 and conformation.13 The 
photo-modulation of these properties has the potential to significantly positively 
influence optoelectronic technologies such as waveguides,14 influencing 
biological actions 14 and read/write/erase optical information storage 
systems.10a, 11c 
X X
UV
UV
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I.4 Dithienylethenes 
 
A large number of photochromic compounds are known including azobenzenes, 
spiropyrans, dihydropyrans, fulgides, spirooxazines and dithienylethenes. The 
huge majority of these photoresponsive molecular switches are limited by their 
thermal stability of the electrocyclization reactions, and the difficulties during 
synthesis of functionalized derivatives.5, 6, 8 
Dithienylethenes (DTEs) constitute a class of molecular switches that exhibit 
stability in the open and the closed isomer (bistability), high fatigue resistance 
and easy synthetic access. Due to these properties, DTEs have been the in the 
focues academic and industrial research. Dithienylethenes can be switched 
between the ring-open (A) and the ring-closed isomer (B) isomers, as shown in 
Scheme 1. The ring-open isomer is colourless, and exhibit rotation around two 
sigma bonds (connecting the central ring with the heterocycles) making it 
flexible. Irradiation of the open form with UV-light induces a conrotatory 
electrocyclization to the ring-closing isomer, generating a conjugation which 
gives the molecule its colour and is influenced the R substituents (Scheme 1). 
As the closed isomer is cyclized, it is more rigid than the open version. The DTE 
architecture contains few positions that can be changed, the easiest being the R 
substituent on each thiophene.6  
For combination with biology the photoresponsive dithienylethene exhibits 
several attractive features. They display fatigue resistance and high quantum 
yields compared to other photoresponsive compounds. Secondly, many of 
these properties can be tuned by synthetic variation of the thiophene 
substituents, often without any loss of performance. Therefore these systems 
can be functionalized for either hydrophobic or hydrophilic conditions making 
them suitable for the biological environment. The small scaffold size relative to 
biological macromolecules such as nucleic acids and proteins allows use of 
these in such systems.6 
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Figure 3.      Photochemical reactions of the dithienylethene (DTE) architecture. 
The absorption properties attainable in the ring-closed forms 1b can be fine-
tuned by modifying the groups R1 and R2 at the ends of the pi-conjugated 
backbone.15 
S SR R1 2 S SR R1 2
UV 
VIS 
    1a 
 colorless 
  1b 
colored 
R1, R2 = Cl 
CO2H 
Cl 
yellow 
red 
purple CONHR 
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I.5 Quantum Yield and Photostationary State7 
 
For photochromic performance of DTEs two quantities should be known. The 
first is the quantum yield (Φ) which gives information about the efficiency of the 
electrocyclization reactions. It is defined as the ratio of the number of mcyclized 
olecules to the total number of absorbed photons.16 
 
 
 
 
  
 
 
 
Equation 1.    Quantum yield and photostationary state. 
 
The second quantity is the photostationary state (PSS), which describes the 
percentage of ring-open molecules that are converted to the ring-closed 
isomer.16 
 
 
 
 
 
 
photons absorbed
cyclize that molecules
=Φ
100% x 
molecules of number total
cyclize that molecules
=PSS
 17
I.6 References 
(1) Dessauer, R.; Paris, J. P. Adv. Photchem. 1963, 1, 275-278. 
(2) Wöhrle, D; Tausch, M. W.; Stroher, W.-D. in: Photochemie, Wiley-VCH: 
Weinheim, 1998. 
(3) Hirshberg, Y.  Comptes Rendus de l´Academie des Sciences, 1950, 231, 
903-904. 
(4) Irie, M. Chem. Rev. 2000, 100, 1685-1716. 
(5) Feringa, B.L. (editor). 2001. Molecular Switches. Wiley-VCH, Weinheim. 
(6) Master thesis of Kelly Elizabeth Chapple Cadieux, Simon Fraser 
University/ Vancouver (CA), 2001.  
http://ir.lib.sfu.ca/handle/1892/2317?mode=full 
(7) Dissertation of Anthony James Wigglesworth, Simon Fraser University/ 
 Vancouver (CA), 2006. 
http://ir.lib.sfu.ca/dspace/retrieve/2948/etd2257.pdf 
(8) Organic Photochromic and Thermochromic Compounds; Crano, J. C., 
Guglielmetti, R. J., Eds.; Plenum Press: New York, 1999; Vols. 1 and 2. 
(9) (a) Matsuda, K.; Irie, M. J. Photochem. Photobiol. C: Photochem. Rev. 
2004, 5, 170-182. (b) Tian, H.; Chen. B.; Tu, H.; Miillen, K. Adv. Mater. 
2002, 14, 918-923. (c) Irie, M.; Fukaminato, T.; Sasaki, T.; Tamai, N.; 
Kawai, T. Nature 2002, 420, 759-760. (d) Norsten, T. B.; Branda, N. R. J. 
Am. Chem. Soc. 2001, 123, 1784-1785. (e) Norsten, T. B.; Branda, N. R. 
Adv. Mater. 2001, 13, 347-349. 
(10) (a) Kawai, T.; Nakashima, Y.; Irie, M. Adv. Mater. 2005, 17, 309-314. (b) 
Li, J.; Speyer, G.; Sankey, 0. Phys. Rev. Lett. 2004, 93, 2483-2502 1 4 . 
(c) Guo, X.; Zhang, D.; Yu, G.; Wan, M.; Li, J.; Liu, Y.; Zhu, D. Adv. 
Mater. 2004, 16, 636-640. (d) Dulic, D.; Van der Molen, S . Kudernac, T.; 
Jonkrnan, H. T.; de Jong, J. J. D.; Bowden, T. N.; van Esch, J.; Fering,a, 
B. L. Phys. Rev. Lett. 2003, 91, 207402 1-4 . (e) Tsujioka, Y.; Hamada, 
K.; Shibata, K.; Taniguchi, A.; Fuyuki, T. Appl. Phys. Lett. 2001, 78, 
2282-2284. 
(11) (a) Bertarelli, C.; Bianco, A.; D'Amore, F.; Gallazzi, M. C.; Zerbi, G. Adv. 
Funct. Mater. 2004, 14, 357-363. (b) Kim,, M.-S.; Maruyama, H.; Kawai, 
 18
T.; Irie, M. Chem. Mater. 2003, 15, 4539-4543. (c) Kim, E.; Choi, Y.-K.; 
Lee, M.-H. Macromolecules 1999, 32, 4855-4860. 
(12) (a) Wigglesworth, T. J.; Sud, D. Lekhi, V. S.; Norsten, T. B.; Branda, N. 
R. J. Am. Chem. Soc. 2005, 127, 7272-7273. (b) Kose, M.; Shinoura, M.; 
Yokoyama, Y.; Yokoyama, Y. J. Org. Chem. 2004, 69, 8403-8406. (c) de 
Jong, J. J. D.; Lucas, L. N.; Kellogg, R. M.; van Esch, J. H.; Feringa, B. L. 
Science 2004, 304, 278-301. (d) Yamamoto, S.; Matsuda, K.; Irie, M. 
Org. Lett. 2003, 5, 1769-1772. (e) Pieraccini, S.; Masiero, S.; Spada, G. 
P.; Golttarelli, G. Chem. Commun. 2003, 598-599. ( f ) Murguly, E.; 
Norsten, T. B.; Brancla, N. R. Angew. Chem. Int. Ed. 2001, 40, 1752-
1755. 
(13) (a) Kang, J.-W.; Kim, J.-J.; Kim., E. Appl. Phys. Lett. 2002, 80, 1710-
1713. (b) 
Kang, J.-W.; Kim, J.-J.; Kim, E. Optical Materials 2002, 21, 543-548. 
(14) Vomasta, D.; Högner, C.; Branda, N. R.; König, B. Angew. Chem. Int. Ed. 
2008, 47, 7644. 
(15) Lemieux, V.; Gauthier, S.; Branda, R. N. Angew. Chem. Int. Ed. 2006, 
45, 6820-6824. 
(16) (a) Irie, M. in Molecular Switches; Feringa, B. L., Ed.; Wiley-VCH: 
Weinheim, Germany, 2001. pp 37-60. (b) Irie, M. in Organic 
Photochromic and Thermochromic Compounds; Crano, J. C., 
Guglielmetti, R. J., Eds.; Plenum Press: New York, 1999; Vol. 1, pp 207-
221. (c) Tian, H.; Yang, S. Chem. Soc. Rev. 2004, 33, 85-97. (d) Irie, M. 
Chem. Rev. 2000,100, 1685-1716. 
 19
 
Regulation of Human Carbonic Anhydrase I (hCAI) Activity by 
Using a Photochromic Inhibitor11 
 
 
 
This chapter deals with the use of photoresponsive 1, 2 dithienylethenes (DTE), 
decorated with a Cu(II)-ida complex and a sulphonamide, as an inhibitor for 
human carbonic anhydrase I. With the help of these molecules it is possible to 
influence biological actions, in this case enzyme activity, by light. 
 
The knowledge of synthesis and handling of dithienylethenes was gained during 
a research stay at the Simon Fraser University (SFU) in Vancouver/Canada in 
the group of Prof. Dr. Neil Branda. The synthesis of the control compounds 7 
and 8 was done by Christina Högner under the supervision of Daniel Vomasta 
(F-Praktikum). The synthesis of the other compounds as well as all the 
measurements was done by Daniel Vomasta. 
                                                 
1
 Vomasta, D.; Högner, C.; Branda, N.R.; König, B. Angew. Chem. 2008, 120, 
7756-7759; Angew. Chem., Int.Ed.Engl. 2008, 47, 7644 – 7647 
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II. Regulation of Human Carbonic Anhydrase I (hCAI) Activity 
by Using a Photochromic Inhibitor 
 
II.1 Introduction 
The regulation of enzyme activity is crucial for the metabolism of every 
organism. In biology, enzymatic control is typically achieved through the use of 
allostery1 or by covalently modifying the enzyme (by phosphorylation or 
dephosphorylation, for example).2 Some of the origin attempts to artificially 
influence the activity of enzymes rely on chemical modifications of the enzyme 
structure,3–6 an approach that is limited by the fact that the regulation is not 
reversible. The use of light as a stimulus offers a heightened level of control, 
and photoresponsive compounds would provide the reversibility needed for 
practical use. Existing examples of systems that take advantage of the 
beneficial properties of light include those that use azobenzene-based enzyme 
inhibitors7 or use thiophenfulgide derivatives covalently linked to the enzyme’s 
structure.8 Photoinducing changes in the environment around the enzyme has 
also been used as a regulation mechanism by influencing the permeability of a 
photoisomerizable polymer containing the enzyme for the substrate, 8 by 
controlling the conformation of a specific domain of the enzyme with 
surfactants9 and by changing the conditions of the medium (pH or viscosity, for 
example).10 
Controlling the activity of carbonic anhydrase is of special interest as it is an 
enzyme central to both cellular transport and metabolic processes. It can be 
found in virtually every tissue and cell type, in many subcellular organelles, and 
in organisms ranging from unicellular cyanbacteria to mammals.11 Recently, an 
azobenzene-based biolabel was used to photomodulate the activity of carbonic 
anhydrase (about twofold).12 Although controlling enzyme activity with 
azobenzene derivatives is an elegant concept, the thermal reversibility that 
plagues these particular photoresponsive compounds significantly limits their 
use in practical applications. On the other hand, compounds constructed from 
the 1,2-dithienylethene (DTE) scaffold represent a significant improvement over 
most other photoresponsive structures, 
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 primarily because they undergo thermally irreversible photochemical ring-
closing and ring-opening reactions (see, for example, the substructures 1o  
1c in Scheme 1).13 
In this communication, we describe how this versatile photoresponsive structure 
can be used to reversibly control the activity of carbonic anhydrase by 
decorating the DTE architecture with sulphonamide and copper(II)iminodiacetic 
acid (Cu•IDA) moieties. These two moieties were chosen in light of Mallik’s 
recently reporting a significant increase in the activity of the weak enzyme 
inhibitor sulphanilamide (4-aminobenzenesulfonamide, 4) when covalently 
combined with a Cu•IDA complex.14 
 22
II.2 Results and discussion 
 
1o
(48 % for 2 steps)
S S
S S
N
O
H
N
O
H
S
H2N
O O
N
O
O
O
O
Cu
1c
(99 %)
N N
O
H
SH2N
O O
N O
O
O
O
Cu
O
H
2
S SHO2C CO2H
SO2NH2
H2N
H2N
N
CO2t-Bu
CO2t-Bu
5
    (49 % for 3 steps)
S S
N
O
H
N
O
H
S
H2N
O O
N
4
3
CO2t-Bu
CO2t-Bu
1. HCl, Et2O, CH2Cl2
2. NaHCO3, CuCl2, CH3OH,CH3CN
> 434 nm
312 nm
1. SOCl2, THF, DMF
2. 
    Et3N, THF
3.
ring-open
flexible backbone
ring-closed
rigid backbone
 
 
Scheme 1. Synthesis and the reversible photochemical ring-closing reaction 
of DTE inhibitor 1o. 
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While the sulphonamide group in 1o acts as the inhibitor, the role of the Cu•IDA 
component is to reversibly coordinate to the imidazole side-chains of the 
histidine amino acids exposed on the protein surface close to the Zn(II) active 
site of the enzyme and help dock the sulphonamide inhibitor group into the 
catalytic centre. Given the fact that the activity of any two-pronged enzyme 
inhibitor is directly dependent on the distance and relative orientation of the two 
groups (in this case, the Cu•IDA and the sulphonamide) and the fact that the 
DTE architecture can be toggled between a flexible, ring-open (1o) and rigid, 
ring-closed (1c) isomer,15 we designed compound 1 to reversibly photoregulate 
enzyme activity without having to resort to chemical modifications or changes in 
the natural environment of the enzyme. How the structures of these two 
photoisomers affect carbonic anhydrase activity will be discussed in more detail 
after the results are presented.  
The synthesis of compound 1o is shown in Scheme 116 and starts by stepwise 
coupling the acid chloride of 1,2-bis(5-carboxy-2-methylthien-3-yl)cyclopentene 
217 with [(4-aminobenzyl)-tert-butoxycarbonylmethylamino]acetic acid tert-butyl 
ester (3) and sulphanilamide (4). After removing the two tert-butyl groups with 
acid, treatment with CuCl2 under basic conditions affords the final compound, 
1o in good yield. 
 
Figure 1. Changes in the UV–Vis absorption spectra of an aqueous DMSO (5 
% v/v) solution (1.08 × 10–5 M) of 1o when irradiated with 312 nm light. 
Irradiation periods are 0, 3, 5, 8, 10, 14, 17, 20 and 34 s. The solution also 
contains Tris sulphate buffer (20 mM, pH 8.3). The inset illustrates the change 
in colour of the solution from colourless to purple as the ring-closed isomer is 
generated. 
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Irradiating an aqueous 5% DMSO solution of 1o (Tris sulphate buffer, 20 mM, 
pH = 8.3 at 25 °C) with 312 nm light18 results in the immediate changes in the 
UV-Vis absorption spectra that are typical for photoresponsive DTE derivatives. 
The high-energy band (λmax = 290 nm) decreases in intensity and an absorption 
band in the visible spectral region (λmax = 545 nm) appears as the solution 
changes from colourless to purple due to the formation of the ring-closed isomer 
1c (a smaller band at λmax ~ 360 nm also appears). These spectral changes are 
complete after 34 sec of irradiation (at a concentration of 1.08 × 10–5 M) and a 
photostationary state containing at least 99% of the ring-closed isomer is 
generated according to HPLC analysis of the reaction mixture. This effective 
photoconversion attests to the versatility of the dithienylethene backbone as a 
photoresponsive architecture on which to build practical devices. The high 
photostationary state is highly beneficial and a lower amount of 1c in the 
photogenerated mixture would make the differences in enzyme inhibition 
significanlty less pronounced. The solution containing the ring-closed isomer is 
very stable at room temperature as long as it is kept in the dark, and the colored 
state did not revert back to its colorless form even after 6 months. Irradiation of 
the coloured solution with visible light (λ > 420 nm) converts the ring-closed 
isomer back to 1o and regenerates the original absorption spectrum. This ring-
closing/ring-opening cycle can be repeated at least seven times without any 
sign of degradation. 16 
CO2   +   H2O HCO3–   +   H+
hCAI (1)
 
The human carbonic anhydrase I (hCAI)-catalyzed hydration of carbon dioxide 
(equation 1) is a convenient probe that can be used to investigate the inhibitory 
effect of the photoresponsive DTE compound in its ring-open (1o) and ring-
closed (1c) states.16 The known inhibitor, sulphanilamide 4,19 and 
photoresponsive compounds 7–9 provide excellent controls for comparison. All 
results are presented in Figure 2 and Table 1. 
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Sulphanilamide 4 has an IC50 value of 0.46 µM, which is in good agreement 
with that reported in the literature.[20] The ring-closed DTE isomer 1c has a 
similar inhibition effect (IC50 = 0.4 µM) as that of sulphanilamide. The similarity 
of the inhibitor strength of 4 and 1c suggests that only the sulphonamide 
component interacts with the active site of the enzyme in the latter compound. 
This is likely due to the planar and rigid backbone in 1c preventing the 
simultaneous binding of the Cu•IDA and sulphonamide components as will be 
elaborated on later in this communication. 
On the other hand, the ring-open counterpart (1o) inhibits the enzyme much 
more significantly and its inhibition activity is two orders of magnitude higher 
(IC50 = 8 nM) than both 4 and 1c. This increase can be attributed to the 
structural flexibility of ring-open isomer 1o, which allows both recognition 
components to bind to the enzyme and leads to a higher overall binding affinity. 
The photoresponsive bis(sulphonamide) 7 shows similar inhibition as 
sulphanilamide 4 and no difference between the activity of the ring-open (IC50 = 
0.53 µM) and ring-closed isomers (IC50 = 0.57 µM) can be observed. 21 In the 
case of the photoresponsive bis(IDA) 8, the IC50 values are lower than 
sulphanilamide 4 and but once again, no significant difference between the ring-
open (IC50 = 1.55 µM) and the ring-closed isomers (IC50 = 1.46 µM) is 
measured. The photoresponsive bis(ethyleneglycol) DTE 9 was synthesized to 
investigate whether the dithienylethene unit itself has an influence on the 
enzyme activity. This compound shows no inhibition in the hCAI catalyzed 
hydration of carbon dioxide. All observed changes in the enzyme’s activity can, 
therefore, be ascribed to the synergistic roles the sulphonamide and the Cu•IDA 
groups play as well as to their relative spatial orientation to each other. The 
binding affinities (Ki) of all compounds show similar trends (Table 1). The 
exception is ring-open isomer 1o, which more 
effectively binds to the enzyme (Ki = 0.005 µM for 1o as compared to ~ 0.29–
1.16 µM for 1c, 4, 7o, 7c, 8o and 8c). The reversible DTE ring-closing and ring 
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opening cycle, converting 1o into 1c and back, is also possible in the presence 
of the enzyme.16 
 
Figure 2. Change in % activity of hCAI when the concentrations of compounds 
1, 4 and 7–8 in their ring-open and ring-closed forms are varied.16 The data 
were obtained in an enzymatic assay that monitored the reaction of carbon 
dioxide and water to generate hydrogen carbonate (equation 1). 22 
 27
  
IC50 (µM) Ki (µM)[a] 
inhibitor 
ring-open ring-closed ring-open ring-closed 
4 0.46 ± 0.01 0.29 ± 0.007 
1 0.008 ± 0.0003 0.40 ± 0.005 0.005 ± 0.0002 0.30 ± 0.003 
7 0.53 ± 0.007 0.57 ± 0.01 0.34 ± 0.005 0.35 ± 0.008 
8 1.55 ± 0.8 1.46 ± 0.15 1.16 ± 0.05 1.00 ± 0.01 
9 none none none none 
     [a] The values of Ki were obtained using the Cheng-Prusoff equation.[16] 
Table 1. IC50 values and Ki binding affinities of compounds 1, 4 and 7–9 in their 
ring-open and ring-closed forms. 
 
As eluded to throughout this communication, we can explain the differences in 
inhibition and binding affinity of the two photoisomers of DTE 1 by comparing 
the differences in their conformational flexibility. The flexible ring-open form 1o 
was designed to allow the simultaneous docking of the sulphonamide and the 
Cu•IDA components onto the enzyme surface. This is possible due to the free 
rotation around the C–C single bonds joining the two thiophene heterocycles to 
the central cyclopentene ring, which allows the inhibitor to adopt a geometry 
appropriate for bivalent binding only when in its ring-open form. The structure of 
the enzyme active site (containing both sulphonamide and Cu•IDA components) 
illustrated in Figure 3 clearly reveals the need for geometric adaptation. The 
distance between the two binding components (~10 Å) and the way they project 
in space can only be satisfied by 1o. 
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Although the distance between the sulphonamide and Cu•IDA components is 
the same when the anti-parallel conformation of 1o is converted into its ring-
closed counterpart (Figure 3), it is the parallel conformation of 1o that is the 
likely candidate for bivalent binding to the enzyme. The planar, rigid backbone 
found in the ring-closed isomer 1c forces the two components away from each 
other in a non-productive manner, allowing only one of the components to bind 
to the enzyme at a time. This reduces binding and inhibition. 
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Figure 3. Illustration of the hCAI, catalytic centre containing a sulphanilamide, 
an IDA and one of the surface exposed imidazole groups. The distance 
between and relative positioning of the sulphanilamide and IDA groups can only 
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be satisfied by the ring-open form of compound 1, which can adopt the 
productive parallel conformation. The structure of the enzyme with 
sulphanilamide in the active site was derived from crystal structure data, 
generated and rendered with the program PYMOL from Graph Pad. From 
Mallik’s results15 the length of the inhibitor to guarantee a high binding affinity is 
known. 
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II.3 Conclusion 
 
We have demonstrated that by using a well-designed, two-pronged inhibitor and 
appropriate wavelengths of light, the enzyme activity can be reversibly and 
significantly enhanced by toggling the DTE between a high- and a low-affinity 
conformation. The thermal stability, nearly quantitative formation of each 
photoisomer and activation with visible light makes the system a suitable tool for 
the reversible regulation of enzyme activity by an external light input. The use of 
visible light to activate the inhibitor is particularly important as it will allow better 
penetration into tissue and reduce the amount of damage caused by higher 
energy UV light. 
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II.5 Supporting information 
 
Synthesis and characterization of new compounds 
 
General. Thin layer chromatography (TLC) was performed on alumina plates 
coated with silica gel (Merck silica gel 60 F 254, layer thickness 0.2 mm). 
Column chromatography was performed on silica gel (70–230 mesh) from 
Merck. Starting materials were purchased from either Acros or Sigma-Aldrich 
and used without any further purification. Solvents were purchased from Aldrich 
and used without further purification except for dry THF, which was prepared by 
distillation from potassium. 1,2-Bis(5-carboxy-2-methylthien-3-yl)cyclopentene1 
and 2-(2-methoxyethoxy)-ethylamine2 were prepared according to literature 
known procedures. 
Techniques. Melting points (MP) were determined with a Büchi SMP 20. IR-
spectra were recorded with a Bio-Rad FTS 2000 MX FT-IR spectrometer. NMR 
spectra were recorded on a Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 
MHz, T = 300 K) or a Bruker Avance 300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 
300 K). The spectra are referenced against the NMR-solvent and chemical 
shifts are reported in ppm. The symbol “+” stands for an NMR signal with 
positive intensity in the DEPT 135 spectra indicating a CH or CH3 carbon. The 
symbol “–“ stands for an NMR signal with negative intensity in the DEPT 135 
spectra indicating a CH2 carbon. MS-Spectra were determined on a Varian CH-
5 (EI), a Finnigan MAT 95 (CI; FAB and FD) or a Finnigan MAT TSQ 7000 
(ESI). UV–Vis absorption spectroscopy was performed using a Cary 50 Bio 
spectrophotometer. 
Photochemistry. Standard hand-held lamps used for visualizing TLC plates 
(Herolab, 6 W) were used to carry out the ring-closing reactions at 312 nm. The 
ring-opening reactions were carried out using the light of a 200 W tungsten 
source that was passed through a 420 nm cut-off filter to eliminate higher 
energy light. The power of the light source is given based on the specifications 
supplied by the company when the lamps were purchased. A light detector was 
not used to measure the intensity during the irradiation experiments. 
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Scheme S1. Synthesis of starting material 3. 
Synthesis of [(4-amino-benzyl)-tert-butoxycarbonylmethylamino]acetic 
acid tert-butyl ester (3). In a 250 mL round-bottom flask, a mixture of 4-
aminobenzylamine (1.9 mL, 16.4 mmol), tert-butylbromoacetate (4.6 mL, 31.1 
mmol, 1.9 equiv), K2CO3 (9.0 g, 65.5 mmol, 4.0 equiv), KI (5.4 g, 32.7 mmol, 2.0 
equiv) and CH3CN (100 mL) was heated at reflux for 25 h. After cooling to room 
temperature, the precipitate was filtered off washed with CH3CN and the solvent 
was removed in vacuo. Purification by column chromatography (silica, 
EtOAc/petroleum ether 3:2, Rf = 0.48) afforded 3.4 g (9.7 mmol, 59 %) of 
compound 3 as a pale yellow solid. 
1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.45 (s, 9H, CH3), 3.38 (s, 4H, CH2), 1.72 
(br s, 2H, NH2), 3.75 (s, 2H, CH2), 6.62 (d, 3J = 8.5 Hz, 2H, CH), 7.14 (d, 3J = 
8.2 Hz, 2H, CH); 13C-NMR (75 MHz, CDCl3): δ [ppm] = 28.20 (+), 54.90 (–), 
56.99 (–), 80.75 (Cquat), 114.97 (+), 128.31 (Cquat), 130.30 (+), 145.61 (Cquat), 
170.72 (Cquat); CI-MS (NH3): m/z (%) = 351.2 (100) [MH+]; PI-EI MS: calcd.: 
350.2206, found: 350.2207; MP = 83 °C; FT-IR (ATR): v [cm–1] = 3462 (m), 
3372 (m), 2976 (w), 2828 (w), 1731 (s), 1623 (m), 1518 (m), 1457 (w), 1423 (w), 
1369 (m), 1283 (m), 1252 (m), 1213 (m), 1134 (s), 987 (m), 941 (w), 831 (m), 
756 (w), 592 (m), 523 (m). 
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Scheme S2. Synthesis of photoresponsive DTE 1o. 
Synthesis of (tert-butoxycarbonylmethyl-{4-[(5-methyl-4-{2-[2-methyl-5-(4-
sulfamoyl-phenylcarbamoyl)-thiophen-3-yl]-cyclopent-1-enyl}-thiophene-
2-carbonyl)-amino]benzyl}-amino)acetic acid tert-butyl ester (5). Diester 
(5). 
 In a 100 mL round-bottom flask, a solution of 1,2-bis(5'-carboxy-2'-methylthien-
3'-yl)cyclopentene 2 (1.5 g, 4.3 mmol) in dry THF (20 mL) was treated with 4 
drops of DMF followed by SOCl2 (3.7 mL, 51.6 mmol, 4 equiv) drop-wise. The 
resulting solution was stirred at room temperature for 15 h, at which time the 
solvent was evaporated in vacuo and the solid residue was dried under high 
vacuum. This residue was dissolved in dry THF (50 mL) under an N2 
atmosphere and treated with Et3N (2 mL, 14.3 mmol) in one portion, followed by 
a solution of [(4-aminobenzyl)-tert-butoxycarbonylmethylamino]acetic acid tert-
butyl ester 3 (0.5 g, 1.4 mmol) in dry THF (20 mL) drop-wise over 4 h. After 
stirring at room temperature for 1.5 h, solid sulphanilamide 4 (1.5 g, 8.58 mmol) 
was added in one portion. After stirring at room temperature for an additional 42 
h, the insoluble materials were filtered off, washed with THF and the filtrate was 
evaporated to dryness. The residue purified by column chromatography (flash 
silica, EtOAc/petroleum ether 3:2, Rf = 0.48) yielding 0.6 
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g (0.7 mmol, 49 %, according to the consumption of 3) of compound 5 as a 
brown solid. 
1H-NMR (300 MHz, CD2Cl2): δ [ppm] = 1.33–1.52 (m, 26H), 1.97–1.98 (m, 4H), 
3.37 (s, 4H), 3.80 (s, 2H), 7.26 (d, 3J = Hz, 2H), 7.47–7.77 (m, 10H), 8.54 (br s, 
1H), 9.13 (br s, 1H); 13C-NMR (75 MHz, CD2Cl2): δ [ppm] = 13.06 (+), 13.77 (+), 
22.98 (–), 38.00 (–), 54.28 (–), 56.41 (–), 120.79 (+), 121.31 (+), 128.13 (+), 
130.49 (+), 134.05 (Cquat.), 134.37 (Cquat), 134.66 (Cquat.), 134.70 (Cquat.), 135.28 
(Cquat), 136.24 (Cquat.), 136.47 (Cquat), 137.23 (Cquat), 137.50 (Cquat), 140.68 
(Cquat), 141.54 (Cquat), 141.86 (Cquat), 159.61 (Cquat), 159.87 (Cquat), 166.86 
(Cquat), 170.60 (Cquat); MP = 160–165 °C; ES-MS (DCM/MeOH + 10 mmol/L 
NH4Ac): m/z (%) = 835.3 (100) [M+H] +; IR (KBr-pellet): v [cm–1] = 3350 (m), 
2958 (w), 2919 (m), 2849 (m), 2361 (m), 1735 (s), 1647 (s), 1594 (m), 1522 (s), 
1449 (w), 1400 (w), 1315 (s), 1247 (m), 1199 (w), 1157 (s), 1098 (w), 1024 (m), 
911 (w), 807 (w), 669 (s), 574 (w), 542 (m), 429 (w); PI LSIMS (CH2Cl2/NBA): 
calcd.: 835.2869 found: 835.2885. 
Synthesis of (carboxymethyl-{4-[(5-methyl-4-{2-[2-methyl-5-(4-
sulfamoylphenyl-carbamoyl)-thiophen-3-yl]-cyclopent-1-enyl}thiophene-2-
carbonyl)amino]benzyl}amino)-acetic acid hydrochloride (10). Diacid (10). 
 In a 50 mL round-bottom flask, a solution of diester 5 (150 mg, 0.18 mmol) in 
CH2Cl2 (5 mL) was cooled to 0 °C and treated with a saturated solution of HCl in 
Et2O (2 mL). After stirring the mixture at room temperature for 140 min, the 
precipitate was collected by vacuum filtration and washed several times with 
CH2Cl2 and dried yielding 92 mg (0.12 mmol, 67 %) of diester 10 as a colorless 
solid, which was used without further purification. 
1H-NMR (300 MHz, MeOD): δ [ppm] = 1.97 (s, 3H), 1.99 (s, 3H), 2.15 (quintet, 
3J = 7.4 Hz, 2H), 2.90 (t, 3J = 7.3 Hz, 4H), 4.16 (s, 4H), 4.53 (s, 2H), 7.49 (d, 3J 
= 8.5 Hz, 2H), 7.75–7.85 (m, 8H); ES-MS (DCM/MeOH + 10 mmol/L NH4Ac): 
m/z (%) = 721.1 (100) [M–H]+; MP = 163–167 °C. 
Synthesis of copper complex 1o. In a 10 mL round-bottom flask, a solution of 
compound 10 (133 mg, 0.17 mmol) in a mixture of CH3OH (5 mL) and CH3CN 
(2 mL) 
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was treated with NaHCO3 (44 mg, 0.52 mmol, 3 equiv) and stirred at 50 °C for 
10 min. A solution of CuCl2 (29 mg, 0.17 mmol, 1 equiv) in CH3OH (0.5 mL) was 
added at 50 °C and the resulting mixture was stirred at this temperature for 24 
h. The precipitate that formed was collected by centrifugation and purified by 
washing the solid pellet in CH3OH. The solid was again collected by 
centrifugation. This purification step was repeated 3 times yielding 92 mg (0.12 
mmol, 71 %) of compound 1o as a light blue solid. ES-MS (H2O/THF 1:1): m/z 
(%) = 782.2 (100) [M–H]+; UV (DMSO): λmax = 294 nm (35000); MP > 200 °C. 
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Scheme S3. Synthesis of bis(sulphonamide) 7o, bis(IDA) 8o and bis(glycol) 9. 
Synthesis of 4,4'-(cyclopentene-1,2-diyl)bis(5-methyl-N-(4-
sulfamoylphenyl)thiophene-2-carboxamide) (7). Bis(sulphonamide) 7. 
 In a 100 mL round-bottom flask, a solution of 1,2-bis(5'-carboxy-2'-methylthien-
3'-yl)cyclopentene 2 (0.5 g, 1.4 mmol) in dry THF (10 mL) was treated with 
SOCl2 (1.9 mL, 26.6 mmol) dropwise, followed by DMF (4 drops). The solution 
was stirred for 
1 h at which time the solvent was evaporated and the residue dried in vacuo. 
The solid residue was dissolved in dry THF (10 mL) under an N2 atmosphere 
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and treated with Et3N (1.8 mL, 4.5 mmol) in one portion, followed by a solution 
of sulphanilamide 4 in dry THF (20 mL), which was added drop-wise over 10 
min. After stirring the mixture for 48 h, the solvent was removed in vacuo and 
the resulting residue was suspended in a mixture of H2O and EtOH (3:56 
mL:mL). The mixture was heated at reflux for 1 h, at which time the solid was 
collected by vacuum filtration, washed with water and air-dried yielding 0.4 g 
(0.6 mmol, 43 %) compound 7 as a colorless solid. 1H-NMR (300 MHz, DMSO): 
δ [ppm] = 1.90 (s, 6H), 2.07–2.14 (m, 2H), 2.86 (t, 3J = 7.5 Hz, 4H), 7.27–7.28 
(m, 4H), 7.28 (br s, 4H), 7.79 (d, 3J = 8.8 Hz, 4H), 7.88 (d, 3J = 9.0 Hz, 4H), 7.91 
(s, 2H), 10.38 (br s, 2H); 13C-NMR (75 MHz, DMSO): δ [ppm] = 14.29 (+), 30.29 
(–), 46.66 (–), 119.62 (+), 126.50 (+), 130.34 (+), 134.22 (Cquat), 135.15 (Cquat), 
136.33 (Cquat), 138.52 (Cquat), 140.92 (Cquat), 141.64 (Cquat), 159.78 (Cquat); FT-
IR (ATR): v [cm-1] = 3331 (m), 3107 (w), 1650 (m), 1591 (m), 1524 (s), 1456 
(w), 1400 (w), 1315 (s), 1249 (m), 1148 (s), 1098 (w), 883 (w), 836 (w), 665 (m), 
576 (m), 540 (m); ES-MS (DCM/MeOH + 10 mmol/L NH4Ac): m/z (%) = 657.1 
(46) [M+H]+, 674.2 (100) [M+H+NH4]+, 655.2 (100) [M–H]+, 691.2 (30) [M+Cl]+, 
715.3 (22) [M+CH3COO]+; PI LSIMS (MeOH/ CH2Cl2/ NBA):  calcd.: 656.0891 
found: 656.0997; MP > 200 °C; UV (DMSO): λmax = 285 nm (21900). 
Synthesis of {[4-({4-[2-(5-{4-[(bis-tert-
butoxycarbonylmethylamino)methyl]phenyl-carbamoyl}-2-
methylthiophen-3-yl)cyclopent-1-enyl]-5-methylthiophene-2-carbonyl}-
amino)benzyl]-tert-butoxycarbonylmethylamino}acetic acid tert-butyl ester 
(11). Tetraester 11.  
In a 100 mL round-bottom flask, a solution of 1,2-bis(5'-carboxy-2'-methylthien-
3'-yl)cyclopentene 2 (0.5 g, 1.43 mmol) in dry THF (10 mL) was treated with 
SOCl2 (1.9 mL, 26.6 mmol) drop-wise, followed by 4 drops DMF. The resulting 
solution was stirred for 1 h at room temperature, at which time the solvent was 
evaporated and the residue dried in vacuo. The residue was redissolved in dry 
THF (10 mL) under an N2 atmosphere and treated with 1.8 mL of Et3N (4.5 
mmol) in one portion, followed by a solution of [(4-aminobenzyl)-tert-
butoxycarbonylmethylamino]acetic acid tert-butyl ester 3 (2.8 g, 8 mmol) in THF 
(10 mL), which was added drop-wise over 1 h. 
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The resulting reaction mixture was stirred overnight and after this period, H2O 
(50 mL) was added. The mixture was extracted with EtOAc (3 x 50 mL) and the 
combined organic phases were further extracted with a saturated NaHCO3 
solution (2 x 20 mL). The combined organic phases were dried (Na2SO4), 
filtered and evaporated. Purification by column chromatography (flash silica, 
EtOAc/petroleum ether 8:2, Rf = 0.9) yielded 0.8 g (0.8 mmol, 55 %) of 
compound 11 as a pale brown solid. 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.44 
(s, 36H), 1.85–2.02 (m, 8H), 2.65 (t, 3J = 7.3 Hz, 4H), 3.71 (s, 8H), 3.82 (s, 4H), 
7.31 (d, 3J = 8.5 Hz, 4H), 7.35 (s, 2H), 7.53 (d, 3J = 8.5 Hz, 4H), 8.08 (br s, 2H); 
13C-NMR (75 MHz, CDCl3): δ = 14.80 (+), 22.48 (–), 28.19 (+), 38.71 (–), 54.98 
(–), 56.96 (–), 79.95 (Cquat), 120.18 (+), 129.70 (+), 130.15 (+), 133.54 (Cquat), 
133.64 (Cquat), 133.72 (Cquat), 135.52 (Cquat), 139.86 (Cquat), 159.04 (Cquat), 
169.59 (Cquat); FT-IR (ATR): v [cm-1] = 3298 (w), 2975 (m), 2924 (w), 1727 (s), 
1626 (m), 1599 (m), 1527 (s), 1455 (m), 1410 (m), 1366 (m), 1248 (w), 1216 
(w), 1139 (s), 988 (m), 880 (w), 815 (w), 742 (w), ES-MS (DCM/MeOH + 10 
mmol/l NH4Ac): m/z (%) = 507.4 (77) [M+2H]+, 1013.6 (100) [M+H]+, 1035 (10) 
[M+Na]+; PI LSIMS (MeOH/CH2Cl2/NBA): calcd.: 1012.4689 found: 1012.4817; 
MP = 149–150 °C. 
Synthesis of {[4-({4-[2-(5-{4-[(Bis-carboxymethyl-amino)-methyl]-
phenylcarbamoyl}-2-methyl-thiophen-3-yl)-cyclopent-1-enyl]-5-methyl-
thiophene-2-carbonyl}-amino)-benzyl]-carboxymethyl-amino}-acetic acid 
hydrochloride (12). Tetraacid 12. In a 50 mL round-bottom flask a solution of 
tetraester 11 (0.2 g, 0.2 mmol) in CH2Cl2 (10 mL) was treated with a saturated 
solution of HCl in Et2O (4 mL) at 0°C. After the addition of the acid, the cool 
bath was removed and the mixture was stirred at room temperature for 16 h at 
which time the solvent was evaporated to dryness to yield 0.1 g (0.12 mmol, 60 
%) of compound 12 as a colorless solid. 
1H-NMR (DMSO, 300 MHz): δ [ppm] = 1.91 (s, 6H), 2.02–2.12 (m, 2H), 2.85 (t, 
3J = 7.3 Hz, 4H), 4.02 (s, 8H), 4.33 (s, 4H), 7.47 (d, 3J = 8.5 Hz, 4H), 7.85 (d, 3J 
= 8.8 Hz, 4H), 8.12 (s, 2H), 10.49 (br s, 2H); FT-IR (ATR): v [cm–1] = 2922 (w), 
2854 (w), 1730 (s) 1638 (s), 1595 (m), 1518 (s), 1414 (m), 1319 (m), 1246 (m), 
1069 (w), 939 (w), 
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881 (w), 817 (m), 741 (w), 660 (w), 597 (w); ES-MS (DCM/MeOH + 10 M 
NH4Ac): m/z (%) = 789.3 (38) [M+H]+, 393.3 (5) [M–2H]2–, 787.4 (100) [M–H]–; 
MP >  200°C. 
Synthesis of the bis(copper) complex 8o. In a 50 mL round-bottom flask, a 
suspension of tetraacid 12 (0.14 g, 0.2 mmol) in a mixture of CH3OH and H2O 
(1:1 v/v, 30 mL) was heated to reflux and treated, at this temperature, with solid 
NaHCO3 (90 mg, 1 mmol, 6 equiv) in one portion, followed by CuCl2 (60 mg, 0.3 
mmol, 2 equiv). After the reaction was heated at reflux for 2 h, the blue 
precipitate was collected by centrifugation and the blue solid washed with H2O 
(20 mL), CH3CN (20 mL) and dried yielding compound 8o (0.13 g, 0.15 mmol, 
88 %) as a blue solid. ES-MS (CH3OH + 10 mM NH4OAc): m/z (%) = 911 (100) 
[M–H]+, 971 (35) [M+CH3COO]+; FT-IR (ATR): v [cm–1] = 1595 (s), 1518 (s), 
1441 (w), 1412 (w), 1375 (m), 1317 (m), 1249 (m), 1088 (w), 1010 (w), 855 (w), 
817 (w), 740 (w), 528 (w); MP > 200 °C; UV (DMSO): λmax = 290 nm (44000). 
Synthesis of 4,4'-(cyclopentene-1,2-diyl)bis(N-(2-(2-methoxyethoxy)ethyl)-
5-methylthiophene-2-carboxamide) (9o). Bis(glycol) 9o. In a 100 mL round-
bottom flask, a solution of 1,2-bis(5'-carboxy-2'-methylthien-3'-yl)cyclopentene 2 
(0.4 g, 1.1 mmol) in a 1:1 (v/v) mixture of CH2Cl2 and THF (10 mL) was treated 
with a catalytic amount of DMF (4 drops), followed by a drop-wise addition of 
SOCl2 (0.3 mL, 0.5 g, 4.52 mmol, 4 equiv). The mixture was stirred at room 
temperature and the conversion monitored by TLC. After 3 h, the solvent was 
evaporated in vacuo, the residue was dried under high vacuum and dissolved in 
THF (20 mL) and treated with pyridine (0.4 mL, 0.35 g, 4.52 mmol, 4 equiv) in 
one portion, followed by 2-(2-methoxyethoxy)ethylamine (0.4 g, 3.4 mmol, 3 
equiv). The resulting red mixture was stirred for 15 h at room temperature at 
which time the solvent was removed by evaporation. Purification by column 
chromatography (flash silica, EtOAc/5% CH3OH, Rf = 0.16) afforded 0.3 g (0.6 
mmol, 50 %) of compound 9o as a colorless oil. 1H-NMR (300 MHz, CDCl3): δ 
[ppm] = 1.89 (s, 6H), 1.99–2.09 (m, 2H), 2.76 (t, 3J = 7.5 Hz, 4H), 3.38 (s, 6H), 
3.53–3.65 (m, 16H), 6.44 (br s, 1H), 7.22 (s, 2H); 13C-NMR (75 MHz, CDCl3): δ 
[ppm] = 14.70 (+), 22.87 (–), 38.56 (–), 39.54 (–), 59.00 (+), 69.79 (–), 70.13 (–), 
71.83 (–), 129.29 (+), 134.45 (Cquat), 134.65 (Cquat), 136.25 (Cquat), 139.86 
(Cquat), 161.84 (Cquat); ES-MS (DCM/CH3OH + 10 mM NH4OAc): m/z (%) = 
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551.2 (100%) [M+H]+, 568.2 (10 %) [M+NH4]+; FT-IR (ATR): v [cm–1] = 3345 
(m), 2863 (m), 1646 (s), 1559 (w), 1528 (m), 1457 (w), 1427 (w), 1349 (w), 1300 
(s), 1246 (m), 1197 (w), 1132 (m), 1088 (s), 1027 (w), 930 (w), 896 (w), 853 
(m), 789 (m), 753 (m), 659 (m), 607 (s), 436 (w); PI-EIMS: calcd.: 551.2171, 
found: 551.2164; UV (DMSO): λmax = 260 nm (32759). 
7o
S S
N
O
H
N
O
H
S
H2N
O O
S
NH2
OO
8o
S S
O
H
N
O
H
N
O
O
O
O
CuNN
O
O
O
O
Cu
9o
S S
N
O
H
N
O
H
O
OCH3
O
H3CO
1o
S SS S
N
O
H
N
O
H
S
H2N
O O
N
O
O
O
O
Cu
1c
(99 %)
N N
O
H
SH2N
O O
N O
O
O
O
Cu
O
H312 nm
S S
7c
(99 %)
N N
O
H
SH2N
O O
O
H312 nm
S S
8c
(99 %)
N N
O
H
N O
O
O
O
Cu
O
H312 nm
S S
9c
(91 %)
N N
O
H
O
H312 nm
O OCH3OH3CO
NO
O
O
O
Cu
S NH2
OO
 
Scheme S4. Photochemical ring-closing reactions of compounds 1o, 7o, 8o 
and 9. 
Photochemical synthesis of the ring-closed isomer 1c. A solution of 
compound 1o (0.5 mg, 0.0007 mmol) in DMSO (1 mL) was irradiated for 15 min 
with a 312 nm lamp in an HPLC vial yielding a purple solution containing the 
ring-closed isomer 1c (> 99 %) according to HPLC (NH4OAc buffer). 
Photochemical synthesis of the ring-closed isomer 7c. A solution of 
compound 7o (0.5 mg, 0.0008 mmol) in DMSO (1 mL) was irradiated for 15 min 
with a 312 nm lamp in an HPLC vial yielding a purple solution containing the 
ring-closed isomer 7c (> 99 %) according to HPLC (NH4OAc buffer). 
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Photochemical synthesis of the ring-closed isomer 8c. A solution of 
compound 8o (0.5 mg, 0.0005 mmol) in DMSO (1 mL) was irradiated for 15 min 
with a 312 nm lamp in an HPLC vial yielding a purple solution of the ring-closed 
isomer (> 99 %) according to HPLC (NH4OAc buffer). 
Photochemical synthesis of the ring-closed isomer 9c. A solution of 
compound 9o (3 mg, 0.005 mmol) in CD2Cl2 (0.7 mL) was irradiated for 30 min 
with a 312 nm lamp in a NMR tube light yielding a red solution of a 
photostationary state containing 91% of the ring-closed isomer according to the 
1H-NMR spectroscopy. The remaining 9% were assigned to the ring-open 
isomer 9o. 1H-NMR (300 MHz, CD2Cl2): δ [ppm] = 1.87 (quintet, 3J = 7.5 Hz, 
2H), 2.00 (s, 6H), 2.78 (t, 3J = 7.4 Hz, 4H), 3.41 (s, 6H), 3.54–3.66 (m, 16H), 
6.27 (br s, 2H), 6.65 (s, 2H). 
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Photochromism 
 
Determination of the photostationary state (PPS) of DTE 1. 
 
Figure S1. Representative HPLC chromatogram for the determination of the 
PSS of compound 1. The chromatograms of isomer 1o (upper) and the solution 
of 1c (lower) generated with 312 nm light are shown. The entire peak for 1o 
disappears and a new one appears at a lower retention time. The small peak 
appearing at 48 min is attributed to a photo-generated side product. The 
conversion from the ring-open to the ring-closed isomer is > 99 %. 
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Photochemical cycling studies. 
a) Bivalent inhibitor 1o. 
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Figure S2. Modulated absorbance (abs.) at 294 nm (open squares = 1o) and 
545 nm (black circles = 1c) during alternate irradiation of a DMSO (1.08 x 10–5 
M) solution of 1o with 312 nm light for 34 s, and greater than 420 nm light for 6 
min. 
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b) Bis(sulphonamide) 7. 
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Figure S3. Modulated absorbance (abs.) at 285 nm (open squares = 7o) and 
550 nm (black circles = 7c) during alternate irradiation of a DMSO (1.00 x 10–5 
M) solution of 7o with 312 nm light for 26 s, and greater than 420 nm light for 10 
min. 
 46
c) Bis(IDA) 8. 
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Figure S4. Modulated absorbance (abs.) at 285 nm (open squares = 8o) and 
545 nm (black circles = 8c) during alternate irradiation of a DMSO (1.0 x 10–5 
M) solution of 8o with 312 nm light for 40 s, and greater than 420 nm light for 5 
min. 
 47
d) bis(glycol) 9. 
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Figure S5. Modulated absorbance (abs.) at 280 nm (open squares = 9o) and 
545 nm (black circles = 9c) during alternate irradiation of a DMSO (5.52 x 10–5 
M) solution of 9o with 312 nm light for 85 s, and greater than 420 nm light for 16 
min. 
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Enzyme activity assay (EC 4.2.1.1) 
 
Materials and methods 
stock solutions code 
Tris sulfate buffer 20 mM, pH 8.3 at 0°C 
([Phenol red] = 5.6 x 10–4 M ) 
A 
distilled water B 
CO2 water (2.46 x 10–3 M)[a] C 
enzyme solution (3.33 x 10–6 M)[b] D 
[a]
 Prepared by bubbling CO2 from a gas bottle through 
200 mL distilled water at 0°C for 10 min. The final 
concentration was determined by precipitation with an 
aqueous 0.1 M Ba(OH)2 solution and back-titration with 1 
N HCl solution. [b] Diluted from a 3.33 x 10–5 M stock 
solution. 
blank samples[a]  test samples[a] 
solution vol (mL)  solution vol (mL) 
A 3.0  A 3.0 
B 0.05  D 0.05 
C 1.0  B 1.0 
[a]
 Stirred at 100 rpm. 
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The enzyme activity was determined using the following equation: 
tblank − ttest
ttest
 
The binding affinity was determined using the Cheng-Prusoff equation: 
K i =
IC50
1= (Csubstrate
Km
)
 
Results. 
a) Bis(sulphonamide) 7. 
 
 
 
Figure S6. Inhibition measurements of bis(sulphonamide) 7 compared with 
sulphanilamide 4. 
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b) Bis(IDA) 8. 
 
Figure S7. Inhibition measurements of bis(IDA) 8 compared with 
sulphanilamide 4. 
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Carbonic anhydrase inhibitors: Two-prong versus mono-prong 
inhibitors of isoforms I, II, IX, XII and XIV exemplified by 
photochromic 1,2-dithienylethene derivatives2 
 
 
 
 
This chapter deals with investigations of photoresponsive inhibitors, synthesized 
in chapter before, to human carbonic anhydras isoforms (hCA I, II; IV, XII) by 
using computer assisted stopped-flow measurements. 
 
All the measurements on enzyme inhibtions were done by Alessio Innocenti, 
from the working group of Dr. Claudiu Supuran (University of Florence). The 
photo-isomerizations during these measurements were done by Daniel 
Vomasta. 
                                                 
2
 Daniel Vomasta, Alessio Innocenti, Burkhard König, Claudiu T. Supuran, 
Bioorg. Chem. Med. Lett. submitted. 
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III. Carbonic anhydrase inhibitors: Two-prong versus mono-
prong inhibitors of isoforms I, II, IX, XII and XIV exemplified by 
photochromic 1,2-dithienylethene derivatives 
 
Abstract 
We investigated the inhibition of five physiologically relevant CA isoforms with 
photochromic 1,2-dithienylethene-based compounds incorporating either a 
benzenesulfonamide and Cu(II)-iminodiacetic acid (IDA)-, bis-
benzenesulfonamide-, bis-Cu(II)-IDA- and bis-ethyleneglycol-methyl ether 
moieties, in both their open- and closed-ring forms. For hCA I the best inhibitors 
were the mono-prong bis-sulfonamide and the bis-Cu-IDA complexes (KIs of 2-3 
nM) in their open form. For hCA II, best inhibitors were the open and closed 
forms of the mono-prong bis-sulfonamide (KIs of 13-18 nM). hCA IX was 
moderately inhibited by these compounds (KIs of 9-376 nM) whereas hCA XII 
and XIV were less susceptible to inhibition (KIs of 1.12 – 16.7 µM). 
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III.1 Introduction 
 
The carbonic anhydrases (CAs, EC 4.2.1.1) are ubiquitous metalloenzymes 
present in prokaryotes and eukaryotes, encoded by at least five distinct, 
evolutionarily unrelated gene families: the α-CAs (in prokaryotes from the 
bacteria domain, algae, cytoplasm of green plants, and vertebrates with 15 
isozymes presently known in humans), the β-CAs (predominantly in bacteria, 
fungi, algae, and chloroplasts of both mono- as well as dicotyledons), the γ-CAs 
(in archaea and some bacteria), the δ-CAs, found so far only in marine diatoms, 
and the recently characterized ξ-CAs, which are cadmium enzymes also 
present in marine diatoms.1-8 CAs catalyze the conversion of CO2 to the 
bicarbonate ion and protons. The active site of most CAs contains a zinc ion, 
which is essential for catalysis. The CA reaction is involved in many 
physiological and pathological processes, including respiration and transport of 
CO2 and bicarbonate between metabolizing tissues and lungs; pH and CO2 
homeostasis; electrolyte secretion in various tissues and organs; biosynthetic 
reactions (such as gluconeogenesis, lipogenesis and ureagenesis); bone 
resorption, calcification; and tumorigenicity.3 
Two main classes of CA inhibitors (CAIs) are known: the metal-complexing 
anions, and the substituted sulfonamides and their bioesters (sulfamates, 
sulfamides), which bind to the metal ion of the enzyme either by substituting the 
non-protein zinc ligand to generate a tetrahedral adduct or by addition of the 
metal coordination sphere, generating trigonal-bipyramidal species.3,4 However 
a critical problem in the design of CAIs with pharmacological applications in the 
treatment and prevention of various diseases is related to the high number of 
isoforms (16 in mammals), their rather diffuse localization in many 
tissues/organs, and the lack of isozyme selectivity of the presently available 
inhibitors.3-5 By attaching amino acid moieties with coordinating metal ion 
properties to the sulfonamide, compounds with interesting activity were 
obtained. Indeed, the polyamino acyl derivatized sulfonamides with tails such as 
IDA (iminodiacetic acid), EDTA (ethylenediamino tetraacetic acid) or DTPA 
(diethylenetraamino pentaacetic acid) as well as their Zn(II), Cu(II) or Al(III) 
complexes were shown to act as very potent CAIs against several isozymes 
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such as CA I, II, IV and IX.9 The idea of this approach is to assure a high 
binding affinity of the inhibitor towards the enzyme through the supplementary 
interaction between the metal present in the CAI and amino acid residues from 
the active site, such as His 64, and therefore increase the inhibitory effect.3, 9, 10 
Another interesting aspect for this type of compounds is to control this effect by 
an external input, such as light, to have an alternative medicinal tool for 
influencing enzyme inhibition.10 Molecules constructed from the photochromic 
diarylethene scaffold decorated with the Cu(II)-IDA (copper(II)-iminodiacetic 
acid) complex11 and a sulfonamide zinc-binding group, were recently shown to 
act as potent inhibitors for the human isoform CA I (hCA I). In such compounds, 
the enzyme inhibition can be also regulated by light.9, 10 Herein, we extend the 
earlier inhibition studies, and report the ability of some of these photochromic 
compounds to selectively inhibit physiologically relevant hCA isozymes such as 
hCA I, II (cytosolic, widespread isoforms) as well as hCA IX, XII and XIV (the 
first two are transmembrane, tumor-associated isozymes recently shown to 
represent promising anticancer targets).2-5 
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III.2 Results and discussion 
 
   
 
Scheme 4: Left: asymmetric two-prong photochromic inhibitor 1o (open) and 
the photo-induced conversion of the diarylethene-scaffold with formation of the 
“closed” isomer 1c. Right: the symmetric compounds 2 (monoprong, bis-
sulfonamide), 3 (bis-Cu-IDA complex) and 4 (used as a control). 
 
The synthesis and photochromic properties of compounds 1-4 (Scheme 1) 
employed in this study were recently reported 10 and will be not discussed here. 
Irradiation12 of the 1,2-dithienylethene (DTE) scaffold of the “open” isomers 1o-
4o with the appropriate wavelengths (312 nm and > 420 nm) induce the ring 
closure due to the cycloaddition reaction, with formation of the “closed” isomers 
1c-4c (Scheme 4). In order to test the efficacy of two-prong versus mono-prong 
derivatives for obtaining isozyme-selective CAIs, the compound 1o/1c 
incorporating a benzenesulfonamide head and a copper-IDA tail, together with 
the corresponding bis-sulfonamides 2o/2c (incorporating two equivalent 
benzenesulfonamide heads) will be compared for their interactions with various 
CA isozymes. For assessing the role of the Cu-IDA moiety for the binding of the 
inhibitors to these enzymes, the compounds 3o/3c (incorporating two equivalent 
Cu-IDA moieties but no sulfonamide zinc-binding group) were also used in our 
experiments, together with the presumably non-CA ligands 4o/4c, which 
incorporate methoxy-ethyleneglycol moieties instead of the 
benzenesulfonamide/IDA moieties present in the CA ligands 1-3, which should 
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have no specific affinity for the CA active site, as they lack structural elements 
that can coordinate to the Zn(II) ion or interact with His residues involved in the 
catalytic cycle.13 
The ring-open isomers 1o and 2o show some structural flexibility due to the free 
rotation around the C-C single bonds joining the two thiophene heterocycles to 
the central cyclopentene ring, which allows the compounds to adopt a geometry 
appropriate for binding to the enzyme by means of the sulfonamide moiety 
(which will be anchored to the Zn(II) ion from the enzyme active site, in the case 
of both 1o and 2o) as well as by the sulfonamide moiety and the copper(II) ion 
(for 1o), which may bind to His64 (or another His residue belonging to the His 
cluster present in the active site of several CA isozymes, such as CA I, II, IX 
and XII among others).13 On the other hand, in the “closed” isomers 1c/2c, the 
free rotation around the C-C single bond is no longer possible (due to its 
incorporation in the 6-membered ring), the flexibility of the compounds being 
drastically reduced.10 Thus, the main difference between the open and closed 
isomers is the drastic change in flexibility of the molecule. Along with this 
conformational change, the spatial distance between the two recognition groups 
present in 1o/1c, i.e., the sulfonamide zinc-binding moiety and the copper-IDA 
moiety that recognized His residues, are changed as well upon irradiation.10 
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** Mean value from at least 3 different measurements.14 Errors were in the 
range of ± 5 % of the obtained value (data not shown). 
 
Table 1: CA inhibition data against isoforms I, II (cytosolic) and IX, XII and XIV 
(transmembrane enzymes) with the photochromic compounds 1-4 (o = opened, 
c = closed isomers) and standard sulfonamide sulfanilamide SA and 
acetazolamide AZA. 
 
Inhibition data against five physiologically relevant CA isozymes, i.e., the 
cytosolic, ubiquitous hCA I and II, the transmembrane hCA IX, hCA XII (tumor-
associated isoforms) and hCA XIV, with compounds 1-4 (in open (o) and closed 
(c) forms) as well as the clinically used sulfonamide standards sulfanilamide SA 
and acetazolamide AZA, are presented in Table 1.14,15  
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The following structure-activity relationship (SAR) can be observed for the 
inhibition of various CA isozymes with compounds 1-4, SA and AZA: 
 (i) Against the slow cytosolic isoform hCA I, compounds 1-3 (in both open 
or closed form) act as very potent inhibitors, with inhibition constants in the 
range of 2-18 nM, in contrast to the DTE-methoxyethylenoxy-ethyl scaffold 
4o/4c which is devoid of any enzyme inhibitory activity. The simple 
sulfonamides SA and AZA are also rather weak inhibitors of hCA I, with KIs in 
the range of 250 nM – 25 µM, as already reported earlier.4,15 It may be 
observed that for the sulfonamide derivatives 1 and 2, the open, more flexible 
isomers 1o and 2o are 3.5 – 9 times more potent hCA I inhibitors as compared 
to the corresponding closed isomer 1c and 2c, respectively, as already 
documented earlier by some of us.10 However, two remarkable new findings 
emerged here. First, the symmetrical bis-sulfonamide derivative 2o (mono-
prong derivative) is two times a better hCA I inhibitor as compared to the two-
prong derivative 1o, although the Cu-IDA moiety should in principle allow a 
supplementary binding16 to the His64 residue situated in the middle of the active 
site cavity and thus further stabilization of the enzyme-inhibitor adduct, over the 
corresponding bis-sulfonamide 2o, which cannot interact with His64 or other His 
residues belonging to the His cluster present in this isoform.13 Thus, this is a 
clear-cut example that the two-prong approach17 is not a general one for 
designing tight binding CAIs, and more than ever isozyme-selective such 
compounds, since a bis-sulfonamide devoid of Cu-IDA moieties (2o) acts as a 
better inhibitor than the two-prong, structurally similar compound (1o). But what 
is even more interesting is the fact that the bis-Cu-IDA derivatives 3o and 3c 
showed equipotent, extremely strong hCA I inhibitory activity (KI of 3 nM), which 
is intermediate between that of the two-prong inhibitor 1o (KI of 4 nM) and the 
mono-prong bis-sulfonamide 2o (KI of 2 nM). Furthermore, the closed ring 
copper(II) complex 3c is by far the best hCA I inhibitor among the closed 
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derivatives 1-3 examined here, with the two-prong 1c (KI of 14 nM) and bis-
sulfonamide 2c (KI of 18 nM) compounds being much less effective inhibitors. 
We cannot explain these data without an X-ray crystal structure for the adduct 
of hCA I with 3o or 3c, but presumably these derivatives may bind to some of 
the His residues present within hCA I active site (His64, His67, His200 and 
His243)13 which lack in other CA isoforms among those investigated here, 
without interaction with the catalytically critical Zn(II) ion from the enzyme cavity. 
 (ii) The ubiquitous, physiologically dominant2 isozyme hCA II is also 
inhibited significantly by sulfonamides 1, 2, AZA and the copper complexes 3 
(KIs in the range of 12-136 nM), being less susceptible to inhibition with 
sulfanilamide SA (KI of 240 nM) and not at all inhibited by the scaffold of 4o/4c 
(Table 1). Again SAR is very interesting, with the open isomers 1o-3o being 
always better hCA II inhibitors than the corresponding closed ones 1c-3c. As for 
hCA I, the two-prong compounds 1o/1c are less effective hCA II inhibitors as 
compared to the mono-prong bis-sulfonamides 2o/2c, but unlike hCA I, the 
copper complexes 3 are generally weaker inhibitors than the sulfonamides 1 
and 2. It should be also noted that simple sulfonamides such as sulfanilamide 
and acetazolamide are much better hCA II than hCA I inhibitors, whereas for 
sulfonamides 1 and 2 incorporating the DTE scaffold, just the opposite is true. 
 (iii) The tumor-associated isoform hCA IX is moderately inhibited by 
compounds 1, 2, 3c and SA (KIs in the range of 54 – 376 nM) being strongly 
inhibited only by the open copper complex 3o and AZA (KIs of 9-25 nM). For 
this isoform, the two-prong inhibitors 1o/1c showed better inhibitory activity as 
compared to the mono-prong ones 2o/2c, but unexplainably the best inhibitor 
does not possess a sulfonamide moiety (3o). The differences of inhibitory 
activity between 3o and 3c are also quite important, with the closed isomer 
being 41.7 times less inhibitory than the open one. 
 (iv) The transmembrane isozymes hCA XII and XIV showed less 
susceptibility to be inhibited by the compounds investigated here, with inhibition 
constants in the range of 1.12 – 15.9 µM, orders of magnitude higher than for 
the isozymes discussed earlier. As for hCA IX, also for hCA XII and XIV the two 
prong inhibitors were slightly more effective than the mono-prong ones, 
whereas the copper complexes 3 showed also a weak inhibitory capacity. 
Whereas derivatives 4 showed no notable interaction with the enzymes 
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discussed above (except 4o with hCA IX), these ethers seem to inhibit 
appreciably (in the low micromolar range) hCA XIV. Further studies are 
warranted to understand the inhibition mechanism of 4 against hCA XIV since 
this compound does not possess an obvious structural motif that should interact 
with the CA active site. 
 
III.3 Conclusion 
 
In conclusion we investigated the inhibition of five physiologically relevant CA 
isoforms with DTE-based compounds incorporating both a sulfonamide and Cu-
IDA, bis-sulfonamide, bis-Cu-IDA and bis-ethyleneglycol-methyl ether moieties, 
in both their open- and closed-ring forms. For hCA I the bst inhibitors were the 
mono-prong bis-sulfonamide and the bis-Cu-IDA complexes (KIs of 2-3 nM) in 
their open form. For hCA II, best inhibitors were the open and closed forms of 
the mono-prong bis-sulfonamide (KIs of 13-18 nM). HCA IX was moderately 
inhibited by these compounds (KIs of 9-376 nM) whereas hCA XII and XIV were 
less susceptible to inhibition (KIs of 1.12 – 16.7 µM).  
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Binding of Phosphates using a Photochromic bis-Zn(II)-cyclen 
Derivative 
 
 
 
This chapter deals with the use of photoresponsive dithienylethenes (DTE), 
decorated with Zn(II)-cyclen moieties, in order to create photoswitchable 
recognition of phosphate dianions. 
 
Synthesis of the compounds as well as all the measurements were done by 
Daniel Vomasta. 
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IV. Binding of Phosphates using a Photochromic bis-Zn(II)-
cyclen Derivative 
 
IV.1 Introduction 
 
Recently, considerable attention has been paid to the design of receptors and 
sensors that have the ability to bind biologically important anions selectively by 
electrochemical or optical response. Anions such as pyrophosphate (PPi) and 
adenosine triphosphate (ATP) play an important role in the energy metabolism 
of organisms and the control of metabolic enzymatic processes.1,2 ATP 
hydrolysis with the concomitant release of PPi is central to many biochemical 
reactions, such as DNA polymerization and the synthesis of cyclic adenosine 
monophosphate (cAMP) catalyzed by DNA polymerase and adenylyl cyclase, 
respectively.1,2 Therefore, synthetic receptors with photoregulated affinity to 
important phosphate anions can be envisaged as a powerful tool in 
biomolecular and medicinal chemistry. Existing examples of photo-regulated 
coordinative binding processes use azobenzenes3-6, spirobenzopyrans7,8 or 
pyrene9 in combination with crown ethers to sense cations, like for example 
caesium and ammonium ions. However, these photoresponsive units lack 
thermal stability and interconvert without irradiation. Therefore diarylethenes 
have been combined with crown ethers to create photoresponsive tweezers for 
various cations.10,11 Molecules that are known to bind phosphate anions in 
water at physiological pH are either Lewis acidic bis-pyridylmethylamine (Zn(II)-
BPA) zinc complexes 12,13 or cyclen (1,4,7,10-tetraazacyclodecane) zinc 
complexes.14,15  
We report the synthesis of photoresponsive bis-Zn(II)-cyclen derivatives using 
dithienylethenes as photochromic unit.16 
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IV.2 Results and discussion 
 
Synthesis 
The synthesis of photoresponsive cyclen derivatives started with the symmetric 
coupling of the acid chloride of compound 317 with protected cyclen 4 or 5 
(Figure 5, see experimental part for their synthesis).  After removal of the 
protecting groups under acidic conditions, neutralization on an ion exchange 
column and treatment with ZnCl2 afforded photoresponsive compounds 1o and 
2o in very good yields. 
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Figure 5. Synthesis of photochromic cyclen-derivatives 1o and 2o and the 
photochemical ring-closing reaction 
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Photochromism 
 
Irradiating an aqueous solution of 1o (HEPES = 2-(4-(2-Hydroxyethyl) - 1-
piperazinyl)-ethansulfonic acid, 50 mM, pH = 7.4, I = 154 mM NaCl, 25 °C) with 
312 nm light resulted in immediate changes of the UV/VIS absorption spectra 
that are typical for photoresponsive dithienylethene (DTE) derivatives. The high 
energy band (λmax= 265 nm) decreases in intensity and an absorption band at 
λmax= 350 nm as well as in the visible spectral region (λmax= 529 nm) appears as 
the solution changes from colourless to red upon formation of the ring-closed 
isomer 1c (Figure 6 left part). These spectral changes are completed after 
irradiation for 60 s (at a concentration of 50 µM), and a photostationary state 
containing at least 95% of the ring-closed isomer is generated according to 1H-
NMR analysis of the reaction mixture. For compound 2 the high energy band 
(λmax= 280 nm) decreases in intensity and an absorption band in the visible 
spectral region (λmax= 490 nm) evolves (Figure 6 right part). These spectral 
changes are completed after irradiation for 140 s (at a concentration of 10 µM), 
and a photostationary state containing at least 92% of the ring-closed isomer is 
generated according to 1H-NMR analysis of the reaction mixture. 
 
 
 
Figure 6. Left: Changes in the UV/VIS absorption spectra of an aqueous 
solution of 1o (50 µM) in HEPES buffer (50 mM, pH 7.4, 154 mM NaCl), when 
irradiated with 312 nm light. Irradiation periods were 0, 2, 4, 6, 8, 11, 14, 18, 22, 
26, 30, 35, 40, 50, 60 s. Right: Changes in the UV/VIS absorption spectra of an 
aqueous solution of 2o (50 µM) in HEPES buffer (50 mM, pH 7.4, 154 mM 
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NaCl), when irradiated with 312 nm light. Irradiation periods were 0, 3, 10, 20, 
30, 50, 70,100,140 s. 
 
This effective photoconversion shows the versatility of the dithienylethene 
backbone as photoresponsive unit.  
 
 
 
Figure 7. Left: Cycle performance of photochromic cyclen-derivative 1. The 
changes in absorbance upon alternate irradiation, with UV- and visible light (312 
nm and > 420 nm), of the ultraviolet band (λmax= 265 nm, black solid line) as 
well as of the visible band (λmax= 529 nm, blue dotted line) were plotted against 
the cycle number. Right: Cycle performance of photochromic cyclen-derivative 
2. The changes in absorbance upon alternate irradiation, with UV- and visible 
light (λ = 312 nm and > 420 nm), of the ultraviolet band (λmax= 280 nm, black 
solid line) as well as of the visible band (λmax= 490 nm, blue dotted line) were 
plotted against the cycle number. 
 
The durability of the photochromic Zn(II)-cyclen derivatives 1 and 2, was studied 
by alternate irradiation with UV-light (λ = 312 nm) and visible light (λ > 420 nm), 
respectively. The absorption band in the UV-region as well as in the visible 
region were followed and plotted against the cycle number (Figure 7). 
Compound 1 shows a fast loss of performance and therefore a high tendency of 
photodegradation. This process is even faster for compound 2. The compound 
is almost completely degraded after only four cycles. This is due to the labile 
amide bond between the dithienylethene scaffold and the zinc(II)-cyclen moiety, 
which is cleaved by UV-light and leads to decomposition of the photochromic 
scaffold. 
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Binding studies 
 
Indicator displacement assay 
 
Photoresponsive Zn(II)-cyclen derivatives 1 and 2 do not emit light upon 
irradiation at their absorbance maximum, neither as the ring-open isomer nor as 
in the ring-closed isomer. Therefore, an indicator displacement assay18,19 was 
used to study the binding of various phosphate anions. 
 
 
 
Figure 8. Cartoon of the indicator displacement method (I = indicator, 
R = receptor, A = analyte). Excitation arrows indicate excitation and emission of 
the indicator (I). 
 
In an indicator displacement assay, a receptor (R) with an affinity for a given 
analyte (A) forms a reversible non-covalent complex with an indicator (I), 
usually a fluorescent or UV/Vis indicator dye. Upon complexation with the 
receptor (R), the spectral properties of the indicator change (shift of the 
absorption maximum, enhancement, wavelength shift or quenching of the 
emission signal). Treatment of the receptor-indicator complex with the analyte 
displaces the indicator from the receptor, thereby restoring the indicator’s 
original spectral properties and signalling the presence of the analyte (Figure 8). 
Coumarine methyl sulfonate (CMS) was used as indicator for the 
photoresponsive Zn(II)-cyclen derivatives 1 and 2,. The maximal excitation 
wavelength of λex = 397 nm of the indicator matches the wavelength range 
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 where compounds 1 and 2 have no absorption (ring open isomers 1o and 2o) 
or a minimum in their absorption intensity (ring-closed isomers 1c and 2c). 
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O
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Figure 9. Indicator coumarine methyl sulfonate (CMS), which is used in the 
indicator displacement assay. The orange colour indicates the groups which are 
presumably interacting with the metal complex. 
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Phosphate analytes 
 
Five different phosphates including mono-phosphates and di-phosphates were 
investigated as the analytes for binding to compounds 1 and 2. 
 
 
 
Figure 10. Representative phosphate anions (ATP, PPi, phenylPO, UMP, 1, 
6-FruPO, all sodium salts) for binding studies with Zn(II)-cyclen derivatives 1 
and 2. Orange atoms indicate potentially interacting atoms. 
 
 
Binding studies for compound 1 
 
Zn(II)-cyclen derivative 1 exhibits high flexibility in the ring-open isomer 1o, due 
to the free rotation around the bond connecting the central cyclopentene ring 
and the thiophene heterocycles as well as in the side-chain connecting the 
Zn(II)-cyclen moiety and the DTE scaffold. In the ring-closed isomer 1c the 
flexibility is reduced, however this isomer is still very flexible due to the flexibility 
of the side-chain. The 
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 affinity of lg K = 4 for the interaction of compound 1o and of compound 1c with 
the indicator (CMS) is comparable (Table 2). The flexibility of both isomers may 
account for this observation and leads to two coordinative aggregates which are 
detected in solution (see experimental part, Figure 23, for an illustration).  
 
Fluorescence titration of CMS with Zinc(II)-cyclen derivative 1: 
 
 
 
Figure 11. Left: Fluorescence titration of CMS (50 µM) in HEPES buffer (50 
mM, physiological pH (7.4), 25°C, I = 154 mM NaCl) with compound 1o and 1c 
(300 µM). Changes in emission intensity are plotted against equivalents (eq) of 
compound 1o and 1c. The inset shows the Job’s plot analysis. Yellow circles 
represent 1o and the solid line represents the best fit of the data. Brown 
squares represent 1c and the solid brown line represents the best fit of the data. 
Right: Changes in fluorescence upon addition of increasing amounts of zinc(II)-
cyclen derivatives. The solid black line indicates the initial spectrum of 
coumarine methyl sulfonate (CMS). 
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Results: 
 
 
aErrors were in the range of ± 10 % of the obtained value (data not shown). 
bITC measurements shown in the experimental section.   
 
Table 2. Results of the fluorescence titration of compound 1 with coumarine 
methyl sulfonate and the comparison with data obtained from isothermal 
titration calorimetry (ITC). 
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The interaction with the analytes showed similar behaviour like for the indicator 
(Table 3). For PPi, also ITC measurements were performed in order to confirm 
the data obtained by fluorescence. 
 
 
              A = analyte; errors were in the range of ± 10 % of the obtained value (data not shown) 
 
  
Table 3. Results of the fluorescence measurements of 1 (50 µM) against 
different analytes (300 µM) in HEPES buffer (50 mM, physiological pH (7.4), 
25°C, I = 154 mM NaCl) as well as the results from ITC measurements for PPi.  
 
Analytes UMP, 1,6-FruPO and PhenylPO do not interact with photo-isomers 1o 
and 1c with a significant larger affinity than CMS as the indicator is not 
displaced. Analytes ATP and PPi are able to displace the indicator and 
therefore an increase in the fluorescence intensity is observed. The difference 
in affinity between the ring-open 1o and the ring-closed isomer 1c are about 
one order of magnitude for PPi. In the case of ATP the binding ability of 1o and 
1c is different as three aggregates could be detected in the ring-open form and 
only one aggregate for the ring-closed isomer. The formed aggregate changes 
and the binding affinities show a drastic change. However, currently no detailed 
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explanation of the different binding situations is available. (For illustrations of 
possible binding motifs see experimental part). 
 
 
Binding studies for compound 2 
 
Compared to compound 1 Zn(II)-cyclen derivative 2 shows larger changes in its 
conformational rigidity upon irradiation with UV-light. Upon irradiation the more 
flexible open isomer of the DTE is converted into the planar-rigid isomer and 
therefore the flexibility of the whole structure is decreased. Although the change 
in conformational constrain is presumably more pronounced in this compound 
compared to 1 the affinity towards CMS is still within the same range (lg K = 4) 
for the ring-open 2o and the ring-closed isomer 2c. Also in this case two 
coordinative aggregates were observed which are present in the solution. (For 
illustrations of possible binding motifs see experimental part, Figure 23). 
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Emission titration of CMS with Zinc(II)-cyclen derivative 2: 
 
 
 
Figure 12. Fluorescence titration of CMS (50 µM) in HEPES buffer (50 mM, 
physiological pH (7.4), 25°C, I = 154 mM NaCl) with compounds 2o and 2c (300 
µM).  
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Changes in emission intensity are plotted against equivalents (eq) of compound 
2o or 2c. The inset shows the Job’s plot analysis. Blue triangles represent 2o 
and the solid line represents the best fit of the data. Green circles represent 2c 
and the solid green line represents the best fit of the data.  
 
Results: 
 
 
aErrors were in the range of ± 10 % of the obtained value (data not shown) 
bITC measurements shown in the experimental section.    
 
 
Table 4. Results of fluorescence titration of CMS with compound 1. Data 
obtained from emission measurements are compared with data obtained from 
isothermal titration calorimetry (ITC). 
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               A = analyte; Errors were in the range of ± 10 % of the obtained value (data not shown) 
 
 
Table 5. Results of the fluorescence measurements of 2 (50 µM) against 
different analytes (300 µM) in HEPES buffer (50 mM, physiological pH (7.4), 
25°C, I = 154 mM NaCl) as well as the results from ITC measurements for PPi. 
 
Table 4 summarizes the response from the displacement assay of the 2-CMS 
complex to several analytes. ITC measurements of the binding of compound 2 
and PPi were performed in order to confirm the data obtained by fluorescence. 
Analytes UMP, 1, 6-FruPO and PhenylPO do not displace CMS from 2o and 2c 
indicating a smaller affinity. Added PPi replaces the indicator (lg K = 5), but 
there are no differences in the affinity of 2o and 2c. However, added ATP does 
not displace CMS in the ring-open isomer 2o, whereas in the ring-closed isomer 
2c ATP is able to remove CMS from the complex (lg K = 4.5). Although CMS 
could not be displaced in the ring-open isomer, this is only indicating an affinity 
lower than the indicator (lg K < 4.8). The exact value for the binding is not 
known, therefore no mechanism explaining the difference in binding affinity 
between ring-open and –closed isomer can be given on the basis of the present 
results.  
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IV.3 Conclusion 
 
Photoresponsive Zn(II)-cyclen derivatives 1 and 2 were synthesized and tested 
for phosphate ion recognition using an indicator displacement assay. 
Compound 1 is conformationally very flexible in the ring-open 1o as well as in 
the ring-closed isomeric form 1c, whereas in complex 2 the conformational 
mobility is controlled by the DTE scaffold presumably leading to more 
pronounced differences in conformational constrains. From the investigated 
analytes only PPi and ATP are able to displace the indicator CMS and therefore 
have a higher affinity towards the complexes 1 and 2 compared to the indicator. 
With both derivatives no distinct coordinative aggregate is observed: In the case 
of derivative 1 affinity changes were in the range of one order of magnitude for 
the analyte PPi. Three coordinative aggregates of ATP with complex 1o were 
detected, whereas in the ring-closed isomer 1c only one single coordinative 
aggregate structure is present as derived from the analysis of the fluorescence 
measurement data. 
In the case of compound 2 affinities for PPi within the same order were 
observed. ATP interacts with the ring-closed isomer 2c with a larger  affinity 
than CMS, whereas in the ring-open form 2o the affinity to ATP is lower than for 
CMS. However, due to the fact that the indicator displacement assay is an 
indirect method, the exact binding constant of 2o to ATP remains unknown and 
no conclusive interpretation about the difference in binding affinity between ring-
open –closed isomer can be made.  
The synthesis of a more rigid system (Figure 13) is suggested to overcome 
problems arising from different aggregates in solution. A larger difference in 
binding affinity to ATP of the ring-open and the ring-closed form is likely.  
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Figure 13. Suggested structure of a more ridgid photoresponsive tetra-Zn(II)-
cyclen-DTE20  
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IV.4 Experimental Part 
 
1. Synthesis and characterization of new compounds  
General. Thin layer chromatography (TLC) was performed on alumina plates 
coated with silica gel (Merck silica gel 60 F 254, layer thickness 0.2 mm). 
Column chromatography was performed on silica gel (70–230 mesh) from 
Merck. Starting materials were purchased from either Acros or Sigma-Aldrich 
and used without any further purification. Solvents were purchased from Aldrich 
and used without further purification except for dry THF, which was prepared by 
distillation from potassium.  
 
Analytical methods. Melting points (MP) were determined with a Büchi SMP 
20. IR-spectra were recorded with a Bio-Rad FTS 2000 MX FT-IR spectrometer. 
NMR spectra were recorded on a Bruker Avance 400 (1H: 400.1 MHz, 13C: 
100.6 MHz, T = 300 K) or a Bruker Avance 300 (1H: 300.1 MHz, 13C: 75.5 
MHz, T = 300 K). The spectra are referenced against the NMR-solvent and 
chemical shifts are reported in ppm. MS-Spectra were determined on a Varian 
CH-5 (EI), a Finnigan MAT 95 (CI; FAB and FD) or a Finnigan MAT TSQ 7000 
(ESI). UV–Vis absorption spectroscopy was performed using a Cary 50 Bio 
spectrophotometer, fluorescence spectroscopy was performed using a Varian 
Cary Eclipse fluorescence spectrophotometer. 
 
Photochemistry. Standard hand-held lamps used for visualizing TLC plates 
(Herolab, 6 W) were used to carry out the ring-closing reactions at 312 nm. The 
ring-opening reactions were carried out using the light of a 200 W tungsten 
source that was passed through a 420 nm cut-off filter to eliminate higher 
energy light. The power of the light source is given based on the specifications 
supplied by the company where the lamps were purchased. A light detector was 
not used to measure the intensity during the irradiation experiments. 
 83
 
 
Figure 14. Synthesis of compound 321 
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tri-tert-Butyl-10-(5-methyl-4-(2-(5-(4,7,10-tris(tert-butoxycarbonyl)-1,4,7,10-
tetraazacyclododecane-1-carbonyl)thiophen-3-yl)cyclopent-1-
enyl)thiophene-2-carbonyl)-1,4,7,10-tetraazacyclododecane-1,4,7-
tricarboxylate (7o). 
3,3'-(Cyclopentene-1,2-diyl)bis(4-methylcyclopenta-1,3-dienecarboxylic acid) 3 
(0.2 g, 0.56 mmol), was dissolved in 10 mL of dry THF and 4 drops of DMF 
were added followed by SOCl2 (0.2 mL, 0.3 g, 2.2 mmol, 4 eq) and stirred at 
room temperature for 1 h. After this period the solvent was evaporated in vacuo, 
the residue dried in high-vacuum for 2 h and was taken up with dry THF under a 
N2-atmosphere. Triethylamine (0.2 mL, 0.2 g, 1.7 mmol, 3 eq) was added in one 
portion followed by solid tri-tert-butyl 1,4,7,10-tetraazacyclododecane-1,4,7-
tricarboxylate (0.5 g, 1.1 mmol, 2 eq) in one portion and the resulting mixture 
was stirred at room temperature for 20 h. The solvent was evaporated in vacuo 
and the residue purified by column chromatography (flash silica, ethyl acetate/ 
petroleum ether 2:1 (v/v), Rf = 0.53) affording 0.6 g (0.5 mmol, 84 %) of the 
product as pale orange solid. 
1H-NMR (600 MHz, CDCl3): δ [ppm] = 1.38 (s, 36 H), 1.40 (s, 18 H); 1.95-2.03 
(m, 8 H), 2.75 (t, 3J = 7.5 Hz, 4 H), 3.30-3.77 (m, 32 H), 7.28 (s, 2 H); 
13C-NMR (150 MHz, CDCl3): δ [ppm] = 14.12, 22.49, 27.70, 28.02, 28.40, 
28.45, 28.77, 38.70, 49.73, 68.39, 80.17, 131.08, 133.41, 134.53, 139.04, 
156.76, 164.77; 
MP: 120-121°C; FT-IR (ATR): 2973 (m), 2927 (m), 1687 (s), 1609 (w), 1466 
(m), 1407 (m), 1364 (s), 1245 (s), 1158 (s), 1102 (s), 969 (w), 858 (w), 776 (s), 
621 (w), 559 (w) ; ES-MS (dichloromethane/CH3OH + 10 mM NH4OAc): m/z 
(%) = 1274.9 (100) [MNH4+], 1257.8 (60) [MH+]; PI-EIMS: calcd.: 1256.6800, 
found: 1256.6756. 
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(5-Methyl-4-{2-[2-methyl-5-(1,4,7,10tetraaza-cyclododecane-1-carbonyl)-
thiophen-3-yl]-cyclopent-1-enyl}-thiophen-2-yl)-(1,4,7,10tetraaza-
cyclododec-1-yl)-methanone. 
Compound 7o (0.4 g, 0.32 mmol) was dissolved in 10 mL of dry 
dichloromethane under a N2-atmosphere and then 11 mL of HCl sat. diethyl 
ether was added. This mixture was stirred in the dark at room temperature for 
20 h. After this period the solvent was removed in vacuo and the residue dried 
in high-vacuum. The resulting colourless solid was then dissolved in H2O (4 mL) 
and passed through a short weak basic ion-exchanger resin (3 g). The H2O was 
removed by lyophilization yielding the product as a brown solid (0.2 g, 
0.32 mmol, quant.).  
1H-NMR (600 MHz, CDCl3): δ [ppm] = 1.98-2.08 (m, 8 H), 2.75 (t, 3J = 7.4 Hz, 4 
H); 3.08-3.15 (m, 8 H), 3.16-3.22 (m, 8 H), 3.30-3.37 (m, 8 H), 3.78 (t, 3J = 4.8 
Hz, 8 H), 7.12 (s, 2 H); 
MP: 183-185°C; FT-IR (ATR): 3293(w), 3237(w), 2962 (w), 1609 (s), 1489 (m), 
1446 (m), 1411 (m), 1361 (s), 1262 (m), 1169 (w), 1115 (w), 1061 (w), 884 (s), 
770 (m), 722 (s), 549 (m), 523 (m); ES-MS (dichloromethane/CH3OH + 10 mM 
NH4OAc): m/z (%) = 329.1 (100) [M+2H+], 657.3 (2) [MH+]; PI-EIMS: calcd.: 
656.3654, found: 656.3528. 
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Compound 2o. 
The bis-cyclen ligand (0.1 g, 0.15 mmol) was dissolved in 5 mL of H2O, solid 
ZnCl2 (0.05 g, 0.33 mmol, 2.2 eq) was added in one portion and the mixture 
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was heated to 80°C for 16 h. The solvent was removed by lyophilization, 
washed two times with ethanol (2 x 14 mL) and with CH3CN (2 x 14 mL) 
yielding 0.1 g (83 %) of a light brown solid. 
1H-NMR (300 MHz, D2O): δ [ppm] = 1.90-1.98 (m, 8 H), 2.69 (t, 3J = 7.3 Hz, 4 
H), 2.95-3.14 (m, 25 H), 3.26-3.28 (m, 13 H), 3.71-3.73 (m,10 H), 7.05 (s, 2 H); 
MP: 155-159 °C, ES-MS (H2O/CH3OH + 10mM NH4OAc): m/z (%) = 452.0 
(100) [M4+ + 2 CH3COO-]; FT-IR (ATR): 3752 (w), 3030 (m), 2830 (m), 1703 
(w), 1669 (w), 1591 (s), 1448 (s), 1363 (s), 1272 (m), 1229 (w), 1102 (w), 1047 
(m), 975 (m), 867 (m), 684 (w), 633 (m), 580 (m), 534 (m); UV (HEPES buffer): 
λmax (ε) = 280 nm (21900). 
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tri-tert-Butyl 10-(2-(5-methyl-4-(2-(5-(2-(4,7,10-tris(tert-butoxycarbonyl)-
1,4,7,10-tetraazacyclododecan-1-yl)ethylcarbamoyl)thiophen-3-
yl)cyclopent-1-enyl)thiophene-2-carboxamido)ethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-tricarboxylate (6o). 
3,3'-(Cyclopentene-1,2-diyl)bis(4-methylcyclopenta-1,3-dienecarboxylic acid) 3 
(0.4 g, 1.0 mmol) was dissolved in dry THF (10 mL), 4 drops of DMF were 
added followed by SOCl2 (0.3 mL, 0.5 g, 4 mmol, 4 eq) in one portion. This 
solution was stirred at room temperature for 1.5 h and the solvent removed in 
vacuo. The residue was dried in high vacuum for 2 h and redissolved in dry THF 
(10 mL) in an N2-atmosphere. Triethylamine (0.4 mL, 0.3 g, 3 mmol, 3 eq) was 
added in one portion followed by solid 10-(2-amino-ethyl)-1,4,7,10tetraaza-
cyclododecane-1,4,7-tricarboxylic acid tri-tert-butyl ester (1 g, 2 mmol, 2 eq) and 
the resulting mixture was stirred at room temperature for 20 h. The solvent was 
evaporated in vacuo and the residue purified by column chromatography (flash 
silica, dichloromethane/10% CH3OH, Rf = 0.58). The product was obtained as a 
colourless solid (0.8 g, 0.6 mmol, 66%). 
1H-NMR (600 MHz, CDCl3): δ [ppm] = 1.37 (s, 36 H), 1.39 (s, 18 H), 1.84 (s, 6 
H), 1.88-2.02 (m, 2 H), 2.59-2.75 (m, 16 H), 3.21-3.41 (m, 16 H), 3.42-3.60 m 
(12 H), 6.54 (bs, 2 H), 7.22 (s, 2 H); 13C-NMR (150 MHz, CDCl3): δ [ppm] =  
14.60, 22.76, 28.42, 28.59, 36.46, 38.44, 47.92, 49.89, 51.79, 54.48, 55.19, 
79.31, 79.60, 129.32, 134.32, 134.63, 136.25, 139.82, 161.99; FT-IR (ATR): v 
[cm-1] = 2974 (m), 2932 (m), 1686 (s), 1531 (w), 1460 (m), 1460 (s), 1413 (s), 
1364 (s), 1246 (s), 1153 (s), 1045 (w), 975 (w), 859 (w), 772 (m), 543 (w), 462 
(w); MP: 155-158 °C; ES-MS (dichloromethane/CH3OH + 10 mM NH4OAc): 
m/z (%) = 672.5 (100) [M+2H+], 1344 (16) [MH+]; PI-EIMS: calcd.: 1342.7644, 
found:1342.7576. 
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tri-tert-Butyl 10-(2-(5-methyl-4-(2-(5-(2-(4,7,10-tris(tert-butoxycarbonyl)-
1,4,7,10-tetraazacyclododecan-1-yl)ethylcarbamoyl)thiophen-3-
yl)cyclopent-1-enyl)thiophene-2-carboxamido)ethyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-tricarboxylate. 
Compound 6o (0.4 g, 0.3 mmol) was dissolved in dry DCM (10 mL) and 6 mL of 
an HCl saturated diethylether solution was added in one portion. The resulting 
mixture was stirred at room temperature for 20 h, the solvent was removed in 
vacuo and the solid residue dried under high-vacuum. The solid HCl-salt was 
taken up with H2O (4 mL) and passed through a short weak basic ion exchange 
resin column. Lyophilization of the eluate afforded the product (0.3 g, 0.3 mmol) 
as a pale brown solid. 
1H-NMR (600 MHz, CDCl3):1.83 (s, 6 H), 1.89-2.00 (m, 2 H), 2.57-2.86, 2.95-
3.09 (m, 28 H), 3.30-3.11 (m, 20 H), 3.29-3.38 (m, 4 H), 7.35 (s, 2 H); FT-IR 
(ATR): 1647(w), 1525 (s), 1429 (m), 1384 (m), 1113 (w), 1088 (w), 1014(w), 
937 (w), 869 (w), 723 (w), 560 (m); v [cm-1] =; MP: 160-161°C; ES-MS 
(H2O/CH3OH + 0.1% FAc): m/z (%) = 372.2 (100) [M+2H+], 743.5 (2) [MH+]; PI-
EIMS: calcd.: 742.4499, found: 742.4493. 
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Compound 1o. 
 
The bis-cyclen ligand (0.23 g, 0.3 mmol) was dissolved in 5 mL of H2O and solid 
ZnCl2 (0.01 g, 0.7 mmol) was added in one portion. This mixture was stirred at 
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80°C for 18 h and after this period the solvent was removed by lyophilization. 
The resulting solid was washed with EtOH (2 x 14 mL), yielding complex 1o 
(0.2 g, 0.23 mmol, 75%) as a light brown solid. 
1H-NMR (300 MHz, D2O): δ [ppm] = 1.83-1.99 (m, 8 H), 2.64-2.90 (m, 32 H), 
2.96-3.21 (m, 16 H), 3.35-3.39 (m, 4 H), 7.39 (s, 2H); MP: 183-185°C; ES-MS 
(H2O/CH3OH + 10 mM NH4OAc): m/z (%) = 435.1 (100) [M4+-2H+], 979.2 (1.3) 
[M4+ + 3 Cl-]; FT-IR (ATR): 1620 (w), 1557 (s), 1449 (m), 1302 (m), 1133 (w), 
1084 (w), 1044(w), 967 (w), 871 (w), 753 (w), 530 (m); UV (HEPES buffer): 
λmax (ε) = 265 nm (32759). 
  
 90
N
NN
N
HH
H
N
NN
N
H
H
S S
OO
H
Zn Zn
N
NN
N
H
H
O
H
Zn
N
NN
N
H
H
HO
Zn
S S
312 nm
1o
1c
92%
 
 
 
N
N
N
N
H
H
H
Zn
N
N
N
N
H
H
H
Zn
S S
N
O O
N
HH
N
NN
N
H
H
H
ZnO
N
H
NN
N N
H
H
H
Zn
N
O
H
S S
312 nm
2o
2c
99%
 
 
 
Figure 15. Photostationary states (PSS) of cyclen-derivatives 1 and 2 
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Photochemical synthesis of the ring-closed isomer 2c. A solution of 
compound 2o (2 mg, 0.002 mmol) in D2O (0.7 mL) was irradiated for 30 min 
with a 312 nm lamp in an NMR tube light yielding a red solution containing 92% 
of the ring-closed isomer according to the 1H-NMR spectroscopy in the 
photostationary state. The remaining 8% were assigned to the ring-open isomer 
2o.  
1H-NMR (300 MHz, D2O): δ [ppm] = 1.62-1.77 (m, 2H), 1.89 (s, 6H), 2.33-2.41 
(m, 4H), 3.06-3.20 (m, 18 H), 3.22–3.36 (m, 10 H), 3.60-3.77 (m, 8 H), 6.32 (s, 
2H); 
 
Photochemical synthesis of the ring-closed isomer 1c. A solution of 
compound 1o (2 mg, 0.002 mmol) in D2O (0.7 mL) was irradiated for 30 min 
with a 312 nm lamp in a NMR tube light yielding a red solution containing 95% 
of the ring-closed isomer according to the 1H-NMR spectroscopy in the 
photostationary state.  
1H-NMR (300 MHz, D2O): δ [ppm] = 1.73-1.78 (m, 2 H), 1.87 (s, 6 H), 2.38 (t, 3J 
= 7.3 Hz, 4 H), 2.62-2.64 (m, 4 H), 2.72–2.89 (m, 15 H), 3.00-3.16 (m, 15 H), 
3.33-3.43(m, 6 H); 
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Spectra 
 
Compound 6o: 
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Precursor of 1o: 
 
 
Zn-complex 1o: 
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Zn-complex 1c: 
 
 
 
Compound 7o: 
 
 95
Precursor of compound 2o: 
 
 
 
Zn-complex 2o: 
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Zn-complex 2c: 
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ITC measurements 
 
Compound 1 vs. CMS 
 
 
 
Figure 16. Left: Isothermal titration calorimetry (ITC) studies for the binding of 
the Zn(II)-cyclen derivative 1o to CMS. The top panel on the right shows the 
raw data, generated by titration of 1.43 mL of 0.5 mM 1o by 60 injections (5 µL 
each) of 12 mM CMS. The area under each peak was integrated and plotted 
against the molar ratio 1o to CMS in the right bottom panel. The solid smooth 
line (left) is the best fit of the data according to the two-binding site model for 
the following stoichiometries (N1 and N2), association constants (Ka1 and Ka2), 
and enthalpic changes (∆H°1 and ∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, 
∆H°2 were determined to be 0.75 ± 0.04, 0.6 ± 0.08, (3.2 ± 0.6) x 104 M-1, (2.2 ± 
0.9) x 103 M-1, -1.2 ± 0.07 kcal/mol, and -6.3 ± 0.05 kcal/mol, respectively. 
Right: isothermal titration calorimetry (ITC) studies for the binding of the Zn(II)-
cyclen derivative 1c to CMS. The top panel on the right shows the raw data, 
generated by titration of 1.43 mL of 0.5 mM 1c by 60 injections (5 µL each) of 
12 mM CMS. 1o was irradiated for 25 min with λ = 312 nm before the 
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measurement to generate 1c. The area under each peak was integrated and 
plotted against the molar ratio 1c to CMS in the right bottom panel.  
The solid smooth line (left) is the best fit of the data according to the two-binding 
site model for the following stoichiometries (N1 and N2), association constants 
(Ka1 and Ka2), and enthalpic changes (∆H°1 and ∆H°2). The values of N1, N2, Ka1, 
Ka2, ∆H°1, ∆H°2 were determined to be 1 ± 0.002, 0.6 ± 0.02, (1.3 ± 0.2) x 104 M-
1
, (5.4 ± 0.2) x 102 M-1, -0.9 ± 0.003 kcal/mol, and -6.8 ± 0.06 kcal/mol, 
respectively. 
 
Compound 2 vs. CMS 
 
 
Figure 17. Left: Isothermal titration calorimetry (ITC) studies for the binding of 
the Zn(II)-cyclen derivative 2o to CMS. The top panel on the right shows the 
raw data, generated by titration of 1.43 mL of 0.5 mM 2o by 60 injections (5 µL 
each) of 12 mM CMS. The area under each peak was integrated and plotted 
against the molar ratio 2o to CMS in the right bottom panel. The solid smooth 
line (left) is the best fit of the data according to the two-binding site model for 
the following stoichiometries (N1 and N2), association constants (Ka1 and Ka2), 
and enthalpic changes (∆H°1 and ∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, 
∆H°2 were determined to be 1 ± 0.004, 0.6 ± 0.1, (2.9 ± 0.03) x 104 M-1, (1.0 ± 0) 
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x 102 M-1, -6.5 ± 0.01 kcal/mol, and -1.0 ± 0.4 kcal/mol, respectively. Right: 
isothermal titration calorimetry (ITC) studies for the binding of the Zn(II)-cyclen 
derivative 2c to CMS. 
 The top panel on the right shows the raw data, generated by titration of 1.43 
mL of 0.5 mM 2c by 60 injections (5 µL each) of 12 mM CMS. 2o was irradiated 
for 25 min with λ = 312 nm before the measurement to generate 2c. The area 
under each peak was integrated and plotted against the molar ratio 2c to CMS 
in the right bottom panel. The solid smooth line (left) is the best fit of the data 
according to the two-binding site model for the following stoichiometries (N1 and 
N2), association constants (Ka1 and Ka2), and enthalpic changes (∆H°1 and 
∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, ∆H°2 were determined to be 1 ± 
0.008, 0.65 ± 0.02, (5.0 ± 0.8) x 104 M-1, (6.0 ± 2.0) x 102 M-1, -6.3 ± 0.02 
kcal/mol, and -1 ± 0.2 kcal/mol, respectively. 
 
 
Compound 1 vs. PPi 
 
 
 
Figure 18. Left: Isothermal titration calorimetry (ITC) studies for the binding of 
the Zn(II)-cyclen derivative 1o to PPi. The top panel on the right shows the raw 
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data, generated by titration of 1.43 mL of 0.1 mM 1o by 60 injections (5 µL 
each) of 5 mM PPi. The area under each peak was integrated and plotted 
against the molar ratio PPi to 1o in the right bottom panel. The solid smooth line 
(left) is the best fit of the data according to the two-binding site model for the 
following stoichiometries (N1 and N2), association constants (Ka1 and Ka2), and 
enthalpic changes (∆H°1 and ∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, ∆H°2 
were determined to be 0.9 ± 0.01, 1.7 ± 0, (1.7 ± 0.3) x 105 M-1, (2.8 ± 0.6) x 103 
M-1, -3.2 ± 0.05 kcal/mol, and -1.8 ± 0.1 kcal/mol, respectively. Right: isothermal 
titration calorimetry (ITC) studies for the binding of the Zn(II)-cyclen derivative 
1c to PPi. The top panel on the right shows the raw data, generated by titration 
of 1.43 mL of 0.1 mM 1c by 60 injections (5 µL each) of 5 mM PPi. 1o was 
irradiated for 25 min with λ = 312 nm before the measurement to generate 1c. 
The area under each peak was integrated and plotted against the molar ratio 1c 
to PPi in the right bottom panel. The solid smooth line (left) is the best fit of the 
data according to the two-binding site model for the following stoichiometries 
(N1 and N2), association constants (Ka1 and Ka2), and enthalpic changes (∆H°1 
and ∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, ∆H°2 were determined to be 0.7 
± 0.02, 0.8 ± 0.01, (1.3 ± 0.3) x 106 M-1, (8.2 ± 0.3) x 103 M-1, -1.0 ± 0.05 
kcal/mol, and -6.8 ± 0.08 kcal/mol, respectively. 
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Compound 2 vs. PPi 
 
 
Figure 19. Left: Isothermal titration calorimetry (ITC) studies for the binding of 
the Zn(II)-cyclen derivative 2o to PPi.  The top panel on the right shows the raw 
data, generated by titration of 1.43 mL of 0.1 mM 2o by 60 injections (5 µL 
each) of 5 mM PPi. The area under each peak was integrated and plotted 
against the molar ratio PPi to 2o in the right bottom panel. The solid smooth line 
(left) is the best fit of the data according to the two-binding site model for the 
following stoichiometries (N1 and N2), association constants (Ka1 and Ka2), and 
enthalpic changes (∆H°1 and ∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, ∆H°2 
were determined to be 1.0 ± 0.01, 1.2 ± 0, (2.8 ± 0.2) x 104 M-1, (1.6 ± 0.6) x 102 
M-1, -8.7 ± 0.5 kcal/mol, and 303 ± 96 kcal/mol, respectively. Right: isothermal 
titration calorimetry (ITC) studies for the binding of the Zn(II)-cyclen derivative 
2c to PPi. The top panel on the right shows the raw data, generated by titration 
of 1.43 mL of 0.1 mM 2c by 60 injections (5 µL each) of 5 mM PPi. 2o was 
irradiated for 25 min with λ = 312 nm before the measurement to generate 2c. 
The area under each peak was integrated and plotted against the molar ratio 2c 
to PPi in the right bottom panel. The solid smooth line (left) is the best fit of the 
data according to the two-binding site model for the following stoichiometries 
(N1 and N2), association constants (Ka1 and Ka2), and enthalpic changes (∆H°1 
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and ∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, ∆H°2 were determined to be 0.8 
± 0.02, 0.9 ± 0.4, (1.5 ± 0.4) x 105 M-1, (3.3 ± 0.4) x 103 M-1, -0.5 ± 0.07 
kcal/mol, and -12 ± 6 kcal/mol, respectively. 
 
Indicator displacement assay (IDA) 
 
Compound 1 vs. analytes 
 
 
 
Figure 20. Left: indicator displacement assay (IDA) of the ring-open isomer 
1o (50 µM) against analytes (300 µM) in HEPES buffer (50 mM, I = 154 mM 
NaCl) at physiological pH (7.4). Right: indicator displacement assay (IDA) of the 
ring-open isomer 1c (50 µM) against analytes (300 µM) in HEPES buffer (50 
mM, I = 154 mM NaCl) at physiological pH (7.4). 
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Compound 1 vs. ATP 
 
 
 
Figure 21. Left: fluorescence titration of the ring-open isomer 1o (orange 
triangles and fit) and the ring-closed isomer 1c (blue squares and fit) (50 µM) 
against ATP (300 µM) in HEPES buffer (50 mM, I = 154 mM NaCl) at 
physiological pH (7.4). Right: Job’s plot analysis of 1o (orange, maximum at 
about 0.33) and 1c (blue, maximum at about 0.42) vs. ATP. 
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Compound 2 vs. analytes 
 
 
 
Figure 22. Left: IDA of the ring-open isomer 2o (50 µM) against analytes (300 
µM) in HEPES buffer (50 mM, I = 154 mM NaCl) at physiological pH (7.4). 
Right: IDA of the ring-open isomer 2c (50 µM) against analytes (300 µM) in 
HEPES buffer (50 mM, I = 154 mM NaCl) at physiological pH (7.4). 
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Possible binding motifs: 
 
 
Figure 23. Possible binding motif compound 1 or 2 vs. CMS. Lines in green 
represent compounds 1 and 2 in their ring-open as well as in their ring-closed 
form. 
 
 
Figure 24. Possible binding motif compound 1 or 2 vs. PPi. Lines in green 
represent compounds 1 and 2 in their ring-open as well as in their ring-closed 
form. 
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Figure 25. Possible binding motifs compound 1 or 2 vs. ATP. Lines in green 
represent compounds 1 and 2 in their ring-open as well as in their ring-closed 
form. 
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Bis-indolylethene revisited 
 
 
 
This chapter deals with di-indolylethene as a group of photoresponsive 
diarylethenes, which are known in literature that their ring-closed isomer are 
thermally reversible. This molecule was tested for special features such as 
switching on and off basicitiy, fluorescence and solvent dependency. 
 
 
The syntheses of the compounds as well as the measurements were done by 
Daniel Vomasta. Calculations about the cyclization energy barrier are in 
progress in the group of Prof. Dr. M. Schütz (University of Regensburg). 
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V. Bis-indolylethene - revisited 
 
V.1. Introduction 
Photochromic compounds have received considerable interest because of their 
potential use in optical data storage.1-6 Among such compounds, 1,2-
diarylethenes containing heterocyclic rings are particular promising for practical 
use.1-11 The compounds undergo conrotatory electrocyclic reactions yielding the 
ring-closed isomer which absorb light in the visible region.1 Alteration of the pi-
conjugated chain length of diarylethene derivatives by photoirradiation can be 
used to control reactivity, donor-acceptor interactions, magnetic properties and 
physiological response.12-19 Such triggered changes, induced by light, are 
essential for creation of new materials and devices as well as for molecules of 
biological relevance.20 A phenolic diarylethene that changes its pKa upon 
isomerization was reported by Lehn. The phenolic group acts as the proton 
source and a pyridinium group as the acidifying electron acceptor positioned at 
each end of the diarylethene pi-conjugated chain.21 The acidity increases in the 
closed-ring isomer by the enhanced acceptor effect of the pyridinium ion and 
the connection of the two units was controlled by toggling the switch by light. In 
another example, Irie and co-workers reported the same principle but placed 
the two interacting units in the same aryl unit. Changing the orbital hybridization 
of the reactive carbon from sp2 to sp3 allowed control of the pi-conjugated chain 
length.22 In both examples a modulation of the pKa by about one unit was 
observed. 
Di-indolylethenes (DIE) molecules can have interesting features, but the big 
drawback of these photoresponsive compounds is that diarylethenes with indole 
moieties as the aryl group tend to be thermally reversible. This is due to the 
aromatic stabilization energy of the indole groups, which is larger than that of 
thiophene for example. This effect plays an important role in terms of thermal 
stability.1 However, thermal stability is one very important feature a 
photoresponsive molecule must have to be applicable for various materials. Fan 
and co-workers therefore synthesized various symmetric DIEs with 
modifications in the central ring and at the indole-nitrogen.23 They found that the 
central ring size and the substituent at the indole-nitrogen play a very important 
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role for the thermal stability of these compounds. In terms of this property, a six-
membered central ring (which connects the two indole moieties) and a C-16 
alkyl chain as well as an ethyl-residue at the indole-nitrogen seems to give the 
ring-closed isomers a useful stability for at least 4 to 48 hours at  
room temperature.23 The authors focussed mainly on increasing the thermal 
stability, whereas other properties such as solvent dependency of the thermal 
stability, photostationary states (PSS) and fluorescence were not discussed in 
their publication. The synthetic experimental part provides the general 
procedure for the McMurray reduction for the synthesized compounds, but a 
detailed description of all the other steps is missing. Therefore, we re-
synthesized the compound described as  most thermal stable and tested its 
properties in order to get more information of this class of 1, 2-diarylethenes. 
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V.2 Results and discussion 
 
Synthesis 
 
Starting from commercially available 2-methylindole 2 and subsequent reaction 
with ethylmagnesium bromide followed by quenching with adipoyldichloride 
gives diketone 3. Alkylation under basic conditions and McMurry coupling 
completes the synthesis and affords the desired product 1. 
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Figure 26. Synthesis of photoresponsive bis-indole-cyclohexene 1.23 
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Spectroscopy and photochromism 
 
Di-indolylethene (DIE) 1o emits upon excitation at λex = 297 nm at a wavelength 
of λem = 375 nm (Figure 27, stokes shift ~ 80 nm). 
 
 
 
Figure 27. Absorbance (dotted black line) and emission spectrum (black line) 
of compound 1 (10 µM) in 1, 4-dioxane. 
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Figure 28. Photochromic reaction of DIE 1. Upon irradiation with UV-light 
(λ = 312 nm) an electrocyclic ring-closing reaction takes place (indicated by 
black arrows). This reaction can be reversed to the initial state by addressing 
only the ring-closed isomer through irradiation with visible light (λ > 420 nm). 
Excitation arrows indicate that compound 1o (open) is emitting (λem = 375 nm) 
upon excitation with λex = 297 nm whereas the closed form 1c is non-
fluorescent. Therefore, the closing-reaction can also be monitored by a 
decrease of the fluorescence emission intensity. 
 
 
Irradiation of the indole-switch 1 with UV-light of 312 nm results in immediate 
changes of the UV/VIS absorption spectra at a concentration of 13 µM in 1, 4-
dioxane. The band at λmax = 297 nm decreases in intensity whereas two bands, 
one at λmax = 370 nm and one at λmax = 490 nm, are increasing (Figure 29). This 
affects the colour of the solution as it turns from colourless to red. These 
spectral changes are complete after irradiation for 30 s (13 µM) and a 
photostationary state containing 38% of the ring-closed isomer is generated 
according to the decrease of the fluorescence intensity. 
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Figure 29. Left: UV-profile of compound 1 (13 µM) in 1, 4-dioxane. Upon 
irradiation with λ = 312 nm for 30 s, the photostationary state of the compound 
was reached. The colour changed from colourless to red. The band at 297 nm 
is increasing and new bands (370 nm and 490 nm) are coming up upon 
irradiation. Right: fluorescence emission change upon irradiation with 312 nm 
wavelength in 1, 4-dioxane (13 µM). The fluorescence of the initial state is 
decreasing in intensity and the maximum of the emission shifts from 375 nm to 
357 nm (shift ~ 20 nm). 
 
Also, the fluorescence is influenced by the photo-induced conversion to the 
ring-closed isomer. Upon irradiation with 312 nm for 30 s, the emission band 
decreases and its maximum shifts from 375 nm to 357 nm. Figure 30 shows the 
cycle study of DIE 1 in 1, 4-dioxane (50 µM), the visible band (black line/ 
squares) shows only a slow decrease even after 10 cycles, whereas the 
ultraviolet band (blue line/ circles) the loss of performance starts from the 
second cycle on. Up to date this effect cannot be explained. 
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Figure 30. Performance of compound 1 (50 µM, 1, 4-dioxane) upon alternate 
irradiation with UV-light (λ = 312 nm) and visible light (λ > 420 nm), respectively. 
Changes in the visible band at λ = 490 nm (black line/ squares) and in the 
ultraviolet (UV) band at λ = 297 nm (blue line/ circles) were followed. 
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Solvent dependency of 1c 
 
 
Hypsochromic shift of the visible band 
 
The photo-generated low-energy band of compound 1 is strongly dependant on 
solvent polarity. In THF, benzene, cyclohexane and 1, 4-dioxane a band in the 
visible region at λ = 490 nm evolves. In polar solvents such as acetonitrile 
(Figure 31, left) or tetrahydrofuran/water mixtures, there is a very strong 
hypsochromic shift (~ 150 nm) of the low-energy absorption band of the closed-
isomer (λ = 350 nm).  
 
 
 
Figure 31. Left: UV-profile of compound 1 in acetonitrile (CH3CN, 50 µM). 
The solid black line indicates the initial absorbance of 1o. The arrow indicates 
the band increasing upon irradiation with UV-light (λ = 312 nm). Right: Solutions 
of indole-switch 1 (200 µM) in tetrahydrofurane / water mixtures with increasing 
amount of water (left to right: 0, 20, 25, 33 and 50%). 
 
This hypsochromic shift can be followed by the naked eye (Figure 31, right). 
With increasing amount of water the colour is fading until at 50% water the 
solution is completely colourless. 
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Thermal stability 
 
The thermal stability of indole switches such as compound 1 is controlled by the 
substituent at the indole-nitrogen and by the central ring-size.23 However, as a 
third parameter the thermal stability of DIE depends on the solvent (Figure 32).  
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Figure 32. Thermal stability of 1c in various solvents at room temperature. 
The relative absorbance A/A0 is plotted against time.  
 
For the thermal stability of compound 1c changes of the visible band (λ = 490 
nm) were followed at room temperature, starting from the absorbance intensity 
at the photostationary state (PSS). UV-spectra were recorded after defined time 
periods. 
For solvents like THF, cyclohexane, toluene etc. the compound shows thermal 
stability for at least 1 h. However, increasing the polarity by the addition of even 
small amounts of an polar protic solvent (THF/H2O, 9/1) results in a drastic 
decrease in thermal stability of the closed-ring isomer of compound 1. 
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Light-induced changes in reactivity by dearomatization of indole 
 
In order to investigate light-induced changes in reactivity due to de-
aromatization of the indole moiety (Figure 33) the reactivity of the open- and 
closed-form isomer against Brönstedt acids were tested. 
 
 
 
 
Figure 33. De-aromatization of indole upon irradiation with UV-light 
(λ = 312 nm). The nitrogen lone pair is involved in the aromatic pi-system in the 
open-form isomer 1o, whereas in the closed-form isomer 1c the aromaticity of 
the indole heterocycle is interrupted and the nitrogen atom lone-pair becomes 
more basic. 
 
Due to the light-induced change in the pi-system, the aromaticity of the 
heterocyclic five-membered ring is interrupted. In the case of an indole-
heterocycle the nitrogen lone pair is no longer part of the aromatic system and 
therefore can react as a tertiary amine. In the open-form the lone pair is part of 
the indole heteroarene. 
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Figure 34. Proton-mediated changes in the UV/VIS spectrum of 1 (50 µM, 1, 
4-dioxane) upon addition of two equivalents (eq) of an acid (as an example 
formic acid was chosen). Spectra were recorded every 2 min for a 1 h-period. 
 
Protonation of the nitrogen atom lone pair by a Brönstedt acid induces a rapid 
ring opening of the closed-form 1c yielding isomer 1o. The proton-mediated 
ring-opening reaction can be followed by UV/VIS spectroscopy (Figure 34). 
Upon addition of two equivalents of a Brönstedt acid, for example formic acid, 
the visible band at λ = 490 nm decreases over an hour.  
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Catalyzed rearrangements by electron-withdrawing groups, such as cations 
generated by protonation or Lewis acids, are well known in literature.24-31 
Especially, those using cope rearrangement routes.24-26 Also, 6pi electro-
cyclizations can be catalyzed by electron-withdrawing groups, lowering the 
cyclization energy barrier.29-31  
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Figure 35. Computational example for a 6pi electro-cyclization catalyzed by 
electron-withdrawing groups (marked in red) and – donating groups (marked in 
blue).30 
 
Is a 6pi system decorated with electron-withdrawing groups in C2 and C4 position 
and – donating groups in C1 and C5 position, the cyclization barrier can be 
decreased remarkably by 17-25 kcal/mol (Figure 35).30, 31 
Therefore, we assume that the protonation of the indole-nitrogen atoms, 
generates an electron withdrawing nitrogen cation in the ring-closed (basic) 
isomer and this is induces a rapid reaction to the ring-open (not basic) isomer. 
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It was observed that the strength of the Brönstedt acid is related to the rate of 
the generation of the ring-open isomer 1o indicated by the decreasing visible 
absorption band (Figure 36).  
 
 
 
 
 
 
 
 
 
 
 
Figure 36. Left: Reactivity profile of the reaction of the open-isomer 1o (50 
µM, 1, 4-dioxane) against Brönstedt acids (phosphoric acid = green triangles, 
formic acid = red squares and acetic acid = black squares). Right: Reactivity 
profile of the reaction of the closed-isomer 1c (50 µM, 1, 4-dioxane) against 
Brönstedt acids (phosphoric acid = green triangles, formic acid = red squares 
and acetic acid = black squares). 
 
When adding two equivalents (one equivalent for each nitrogen) of acetic acid 
(pKa = 4.75 in water) to compound 1c no decrease of the visible band can be 
observed. After addition of another twelve equivalents a decrease is visible, the 
conversion is however rather slow. This indicates that the acidity of acetic acid 
is not high enough to protonate the compound which induces the ring opening 
and decreases the visible absorption band of 1c.  In the case of formic acid 
(pKa = 3.75 in water) however, after the addition of two equivalents the visible 
absorption band decreases almost completely within 60 min. After the addition 
of two equivalents of phosphoric acid (pKa = 2.2 in water) to compound 1c the 
absorption band vanished almost immediately (Figure 36 right part), showing 
that instant protonation and therefore decrease of the visible absorption band 
occurs. 
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The open-isomer 1o showed no reaction with Brönstedt acids, after the addition 
of two equivalents of acid (Figure 36 left part). 
 
Due to this observation it can be concluded that the lone-pair of the indole-
nitrogen atom can be activated for protonation by light and reacts as tertiary 
amine.  
 
The pKb value of the nitrogen atoms of 1c is expected to be between the pKb 
values of formate and acetate in 1, 4-dioxane, which are ~ 11 and ~10 
respectively. The photo-generated base has a high structural similarity to 
dimethylaniline, which has a pKb value in the range of about 10.32 Therefore, it 
is concluded that the pKb value of the generated base is in that range. Acetic 
acid is just acidic enough if used in large excess to protonate the nitrogen of 1c 
and induces a decreasing of the visible absorption band. Formic acid is more 
acidic and induces a decrease of the absorption band slowly within 60 min. The 
acidity of phosphoric acid is high (pKa = 2.2). The nitrogens are almost instantly 
protonated and an immediate decrease of the visible absorption band as a 
consequence of a rapid ring opening reaction is observed. 
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V.3 Conclusion 
 
A bis-indole diarylethene 1 was synthesized. The compound shows typical 
characteristics of diarylethene compounds and cyclizes upon alternate 
irradiation with light of an appropriate wavelength. The ring-open isomer shows 
emission, whereas the ring-closed isomer is non-fluorescent. The basicity of the 
compound can be changed by irradiation with UV-light (λ = 312 nm): In the 
open-form isomer the nitrogen atom lone pair is involved in the aromatic system 
of the indole-moiety, whereas in the closed-form isomer it is not. The ring-
closed isomer is readily protonated by acids, such as formic or phosphoric acid, 
but protonation induces the rapid conversion of the closed-form isomer into the 
open-form isomer. The detailed mechanism of this proton-induced reaction is 
unknown, but we assume that it occurs via a concerted reaction, catalyzed by 
protonation of the generated tertiary amines. Computational chemistry 
invesitigations are in progress to unravel the mechanism of the acid catalyzed 
ring-opening reaction. 
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V.4 Experimental Part 
 
1. Synthesis and characterization of new compounds  
General. Thin layer chromatography (TLC) was performed on alumina plates 
coated with silica gel (Merck silica gel 60 F 254, layer thickness 0.2 mm). 
Column chromatography was performed on silica gel (70–230 mesh) from 
Merck. Starting materials were purchased from either Acros or Sigma-Aldrich 
and used without any further purification. Solvents were purchased from Aldrich 
and used without further purification except for dry THF, which was prepared by 
distillation from potassium. 1,2-bis(1-hexadecyl-2-methyl-1H-indol-3-
yl)cyclohex-1-ene 123 is literature known but the synthetic procedure was 
improved.  
 
Techniques. Melting points (MP) were determined with a Büchi SMP 20. IR-
spectra were recorded with a Bio-Rad FTS 2000 MX FT-IR spectrometer. NMR 
spectra were recorded on a Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 
MHz, T = 300 K) or a Bruker Avance 300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 
300 K). The spectra are referenced against the NMR-solvent and chemical 
shifts are reported in ppm. MS-Spectra were determined on a Varian CH-5 (EI), 
a Finnigan MAT 95 (CI; FAB and FD) or a Finnigan MAT TSQ 7000 (ESI). UV–
Vis absorption spectroscopy was performed using a Cary 50 Bio 
spectrophotometer.  
 
Photochemistry. Standard hand-held lamps used for visualizing TLC plates 
(Herolab, 6 W) were used to carry out the ring-closing reactions at 312 nm. The 
ring-opening reactions were carried out using the light of a 200 W tungsten 
source that was passed through a 420 nm cut-off filter to eliminate higher 
energy light. The power of the light source is given based on the specifications 
supplied by the company when the lamps were purchased. A light detector was 
not used to measure the intensity during the irradiation experiments. 
 
1-(1H-Indol-3-yl)-6-(2-methyl-1H-indol-3-yl)hexane-1,6-dione 3. 23 
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Under a N2-atmosphere 2-methylindole 4.52 g (34.28 mmol, 5 eq) was 
dissolved in 50 mL dry THF and cooled to 0°C by an ice/water bath. EtMgBr 
11.43 mL (34.28 mmol, 5 eq) was added dropwise and after the addition the 
mixture was  
refluxed for 60 min. After this period adipoyldichloride (1 ml, 6.86 mmol, 1 eq) 
was added to the refluxing mixture and after the addition refluxing was 
continued for 17 h. The reaction mixture was then quenched by the addition of 
40 mL 1 M HCl und 80 mL H2O. The resulting precipitate was collected by 
vacuum filtration and the solid lyophilized, yielding 1.14 g (3.06 mmol, 45 %) of 
a red solid. 1HNMR (300 MHz, CDCl3): δ [ppm] = 1.72-1.80 (m, 4H), 2.68 (s, 6 
H), 2.88-2.98 (m, 4 H), 7.05-7.19 (m, 4 H), 7.30-7.42 (m, 2 H), 7.94-8.09 (m, 2 
H), 11.62 (bs, 2 H). 
 
 
1,6-Bis(1-hexadecyl-2-methyl-1H-indol-3-yl)hexane-1,6-dione 4.23 
Under a N2-atmosphere compound 3 (0.5 g, 1.3 mmol) was suspended in 10 
mL of dry DMF. NaH (214 mg, 5.36 mmol) was then added in portions and the 
compound dissolved, after the addition the mixture was heated to 40° C for 60 
min. 1-Bromohexadecane (1.64 mL, 5.36 mmol) was added with the help of a 
syringe and stirring was continued at 40°C for further 16 h. The reaction was 
quenched by the addition of 20 mL 1 M HCl und 20 mL H2O and the precipitate 
was collected by vacuum filtration and the resulting solid was dried by 
lyophilization, yielding 0.5 g (0.6 mmol, 76%) of a colourless solid. 
1HNMR (300 MHz, CDCl3): δ [ppm] = 0.88 (t, 3J = 7.0 Hz, 6 H), 1.33-1.25 (m, 56 
H),  1.75 (quintet, 3J = 7.0 Hz, 4 H), 1.92-2.00 (m, 4 H), 2.78 (s, 6 H), 3.06-3.16 
(m, 4 H), 4.11 (t, 3J = 7.5 Hz, 4 H), 7.21-7.26 (m, 4 H), 7.30-7.37 (m, 2 H), 7.92-
8.00 (m, 2 H). 
 
1,2-Bis(1-hexadecyl-2-methyl-1H-indol-3-yl)cyclohex-1-ene 1o. 25 
Under a N2-atmosphere zinc dust (0.3 g, 4.9 mmol, 4 eq) was suspended in 30 
mL dry THF. The suspension was then cooled to -20°C by an acetone/liquid 
nitrogen bath and TiCl4 (0.4 mL, 0.5 g, 2.4 mmol, 2 eq) was added dropwise 
with the help of a syringe. The resulting mixture was then refluxed for 60 min. 
After this period compound 4 was added in four portions and the mixture was 
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refluxed for another 26 h. The black suspension was then poured into a 10% 
aq. K2CO3 solution and stirred at room temperature for 20 min. The resulting 
dark blue slurry was passed through Celite, which was purged several times 
with diethyl ether (20 mL). The two phase system was separated and the 
aqueous phase further extracted with diethyl ether (3 times 50 mL). The 
combined org. phases were dried (Na2SO4), filtered and the solvent removed in 
vacuo. The resulting orange oil was purified by flash column 
 chromatography (flash silica, petroleum ether/ethyl acetate v/v 40/1 to 
petroleum ether/ethyl acetate v/v 15/1, Rf (petroleum ether/ethyl acetate v/v 
15/1) = 0.73) affording 0.3 g (0.4 mmol, 31 %) as a yellow oil. 
1H-NMR (300 MHz, CDCl3): δ [ppm] = 0.88 (t, 3J = 7.0 Hz, 6 H), 1.02-1.27 (m, 
52 H), 1.30-1.43 (m, 4 H), 1.52 (s, 6 H), 1.83-1.94 (m, 4 H), 2.19-2.40 (m, 4 H), 
3.39-3.87 (m, 8 H), 6.79-7.13 (m, 6 H), 7.47-7.57 (m, 2 H). 
 
Photochemical synthesis of the ring-closed isomer 1c 
A solution of compound 1o (2 mg, 2.5 µmol) in C6D6 (0.7 mL) was irradiated for 
30 min with light of a wavelength of 312 nm in an NMR tube yielding a red 
solution of. In this photostationary state the reaction mixture contains 38% of 
the ring-closed isomer 1c according to 1H-NMR spectroscopy. The remaining 
62% were assigned to the ring-open isomer 1o. 
1H-NMR (300 MHz, CDCl3): δ [ppm] = 0.88 (t, 3J = 7.0 Hz, 6 H), 1.02-1.27 (m, 
52 H), 1.30-1.43 (m, 4 H), 1.62 (s, 6 H), 1.83-1.94 (m, 4 H), 1.97-2.07 (m, 4 H), 
3.69-3.97 (m, 8 H), 6.79-7.13 (m, 6 H), 7.47-7.57 (m, 2 H). 
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 Apendix: Spectra 
 
Compound 3 
 
 
 
Compound 4 
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Compound 1o 
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Salen metal complexes and their use in amino acid 
recognition 
 
 
This chapter deals with the well-known salen molecules and their ability in 
molecular recognition. In this chapter some basic investigations have been 
done and discussed. 
 
 
The Ti-salophen complex 3 was synthesized by Julia Sauerwein, under the 
supervision of Daniel Vomasta (F-Praktikum).All the measurements as well as 
the synthesis of the other molecules have been done by Daniel Vomasta. 
 133
VI. Salen metal complexes and their use in amino acid 
recognition 
 
VI.1 Introduction 
 
The development of peptide chemosensors and the specific recognition of 
peptides by synthetic receptors under physiological conditions still remains a 
challenging task. Recently reported approaches used porphyrines, helix mimics, 
crown ethers or short peptides with guanidiniocarbonyl pyrroles as binding sites 
to specifically recognize peptidic structures.1 So far, salen complexes have not 
been used for the molecular recognition of peptidic structures, which is 
surprising as some salen complexes are Lewis-acidic binding sites and the 
compound class is well-studied within the field of homogeneous catalysis.2 
Salen complexes have been used as catalytic species in numerous organic 
transformations including epoxidation of olefins, lactide polymerization, 
asymmetric ring opening epoxides, and Michael reactions,3,4 as well as for 
construction of coordinative frameworks.2 A chiral cobalt(II)-salen complex has 
been used to separate D- and L-amino acids by the simultaneous coordination 
of the C- and N-terminus of only one of the amino acid enantiomers. The Salen 
complex - amino acid aggregate is separated from the remaining amino acid 
enantiomer. Dissociation of the salen-amino acid complex deliberates the 
enantiomerically pure amino acid.5 Metal-salen complexes are easily prepared 
in one step from aldehydes and diamines. Some salen metal complexes show 
luminescent emission upon excitation by light of 330 - 360 nm. The luminescent 
properties can be used to directly monitor guest binding and an additional 
labelling by a fluorescent reporter group, as it is necessary for other metal 
complex binding sites, such as M(II)-IDA (iminodiacetic acid), M(II)-NTA 
(nitrilotriacetic acid) or M(II)-cyclen (1,4,7,10-tetraazacyclodecane)6 is avoided. 
Overall, their simple and cheap synthesis, ease of further derivatization, 
interesting luminescent properties and the ability to reversibly coordinate guest 
molecules renders metal-salen complexes interesting molecular building blocks 
for new chemosensors. 7-10 
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Figure 37. General structure of a symmetric metal-salen complex. The metal 
ion can be used to change the recognition properties of the complex using 
either hard or soft metal ions. The substitution at the aryl rings may be used for 
control of the ligand and complex properties.3 
 
Encouraged by the discussed properties some preliminary investigations of 
selected metal-salen complexes containing Ti(IV), Ni(II), and Fe(III) as the metal 
ions were performed to explore their ability to recognize peptidic structures. 
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VI.2 Results and disucussion 
 
Synthesis of achiral salophen and chiral salen metal-complexes 
 
The synthesis of metal complexes 1 and 2 starts from commercially available 
salicylic aldehyde 6 by formation of imine 7, sulfonation and removal of the 
imine protection group to yield compound 8.11 Schiff base formation and 
simultaneous metal ion coordination gives the salen metal complexes 112, 211 
and 3 in good yields (Figure 38). 
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Figure 38. Synthesis of water soluble and Fe(III)12, Ni(II)11 and Ti(IV) 
salophen-complexes 1, 2 and 3. 
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Figure 39. Synthesis of chiral and water soluble Fe(III) and Ni(II) salen-
complexes 423 and 524 
 
 
The synthesis (Figure 39) of chiral metal-salen complexes 4 and 5 starts from 
chiral ligand 11, which was synthesized by condensation of modified salicylic 
aldehyde 8 with trans-1,2-diamino-cyclohexane (10). The ligand was then 
allowed to react with metal-salts under basic conditions to form complexes 4 
and 5. 
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Figure 40. Representative absorbance (solid black line) and fluorescence 
(dotted black line) spectra of Ni(II)-salophen complex 2 (33 µM, HEPES buffer). 
 
Salophen complexes 1 and 2 show emission with λmax = 428 nm when excited 
at λex = 330 nm. The fluorescence spectrum and the UV-absorption overlap 
significantly (Stokes shift ~ 60 nm).  
 138
Fe(III)-salophen complex 1 
 
The synthesis of iron(III) – salen complexes results always in the formation of 
an oxy- bridged binuclear dimer.12-13 Mass experiments showed the presence of 
a dimeric structure as well as a monomeric structure. Three different 
recrystallization steps from water, ethanol or acetonitrile did not produce the 
pure monomeric or dimeric species. Therefore, the contents of monomeric and 
dimeric complexes in the mixture is unknown, because from the mass 
experiment no conclusion about quantities can be made. 
Binding studies 
 
The ability of complex 1 to bind amino acids or phosphates was investigated in 
aqueous HEPES buffer [HEPES: 2-(4-(2-hydroxyethyl)-1-piperazinyl)-ethan-
sulfonsäure), 50 mM, 154 mM NaCl at pH = 7.4. 
 
 
 139
 
 
Figure 41. Fluorescence intensity change upon addition of amino acids and 
phosphate derivatives (1mM, 10 eq) (green line = PPi, brown line = ATP) to 
Fe(III)-salophen 1 (thick black line = emission without added analyte) using the 
well-plate technique (33 µM, 25 °C, λex = 330 nm, λex = 428 nm). 
Only phosphates PPi and ATP lead to an increase of fluorescence intensity of 
Fe(III)-salophen 1 (Figure 41), whereas the addition of side chain functionalized 
unprotected amino acid, such as aspartic acid, histidine methylester and serine 
caused no change in fluorescence intensity.  
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Figure 42. Left: Fluorescence titration of Fe(III)-salophen complex (1 µM) 1 
with ATP (10 µM). The changes in fluorescence intensity were plotted against 
equivalents of ATP. The inset shows a Job’s plot analysis. Right: Changes in 
fluorescence emission intensity upon addition of increasing aliquots of ATP. 
 
 
The fluorescence titration of the Fe(III)-salophen against ATP showed a distinct 
binding stoichiometry of 1 : 1 and a binding constant of  lg K = 7.7 was derived 
from the measurement. This high affinity towards ATP is attributed to the high 
negative charge of ATP, its ability to act as a bidentate ligand and to the 
oxophilicity of the Fe(III) – ion.  
The poor water solubility of the compound prevented ITC measurements. 
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Ni(II)-salophen complex 2. 
 
Water soluble aromatic Ni(II)-salophen complexes are rarely described in 
literature. They are used for the epoxidation of sytrenes14 and as singlet oxygen 
quenchers.11 The X-ray structure analysis of the parent complex is not known, 
only the structure of the ethylene-diamine complex was reported (Figure 9). 
Mass spectrometric analysis of complex 2 gave no indication of the formation of 
dimeric complexes. 
 
 
 
 
Figure 43. Crystal structure of a possible Ni(II)-salen-dimer (ethylendiamine 
bridging ligand).3,15 
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Binding studies 
 
The binding properties of complex 2 towards amino acids and phosphates were 
investigated by a well-plate screening in aqueous HEPES buffer, 50 mM, at 
pH = 7.4 and 25 °C. 
 
 
Figure 44. Upper left: Fluorescence response of Ni(II)-salophen 2 against 
histidine derivatives (1mM, 10 eq). Upper right: Fluorescence response of Ni(II)-
salophen 2 against aspartic acid (1mM, 10 eq) and N-terminal protected 
aspartic acid (1 mM, 10 eq). Lower: Fluorescence intensity change upon the 
addition of amino acids with functional groups in the side chain (1 mM, 10 eq) to 
Ni-salen-complex 2 using the well-plate technique (Ni(II)-salophen = 33 µM, 
25°C, HEPES buffer 50 mM, 154 mM NaCl, λex = 330 nm, λem = 428 nm). 
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The amino acid screening revealed an increase in fluorescence intensity upon 
addition of histidine and aspartic acid (Figure 37 lower part). Other amino acids 
like serine, cysteine, lysine, and others with a functional group in their side 
chain, induced no increase of the fluorescence intensity. Changes in 
fluorescence intensity can be ascribed to the binding of the respective amino 
acid to the Ni(II)-salophen complex 2 the complex shows selectivity for histidine 
and aspartic acid. This result is quite surprising, as Gennari and co-workers5 
proposed a simultaneous binding of the C- and N-terminus of the amino acid to 
a chiral cobalt(II)-salen complex and therefore no selectivity for any amino acid. 
For the Ni(II)-complex 2 the binding situation is certainly different. The side 
chain of the amino acid must be involved in the interaction with the metal 
complex.  
 
To investigate the histidine binding in more detail we performed a screening 
experiment with histidine, histidine-methylester (HisOMe) and methyl-imidazole 
(Figure 44 upper left). We found that only unprotected histidine and histidine-
methylester interacts with complex 2, showing that the free C-terminus is not 
important for the interaction and that imidazole alone can not interact with the 
Ni(II)-salophen. Only a combination of the N-terminal amino group and the 
imidazole side chain functionality results in strong binding to complex 2.  
For the screening experiment with aspartic acid and N-terminal protected 
aspartic acid (Figure 44 upper right) we found similar results to those obtained 
for histidine. The N-terminal part of the amino acid is important for the binding. 
The bidentate ligand interaction requires a certain distance between the donor 
atoms. This can be concluded from the observation that aspartic acid interacts 
with complex 2 whereas glutamic acid does not. 
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Figure 45. Amino acids and the distance between the coordinating atoms. 
The coordinating donor atoms are marked in red. 
 
The distance between coordinating donor atoms must be five atoms (Figure 
45). If the distance is too large or too small no coordination to complex 2 is 
observed, as in the case of glutamic acid (six atoms) and serine (four atoms). 
 
However, for the Ni-salophen 2, no distinct binding constant as well as binding 
stoichiometry could be obtained for the interaction with histidine and aspartic 
acid using fluorescence measurements. In every case two coordination 
aggregates were observed, which was confirmed by ITC measurements. Due to 
this observation, interpretations about the present structures and therefore 
determination of the corresponding binding constants are rather difficult. 
Investigations with different equivalents of the analyte showed that the 
stoichiometry and the binding constant is dependant on the concentration of the 
complex 2 (for more information see experimental part). In contrast during ITC 
measurements this behaviour was not observed, however two different 
coordination aggregates were obtained one with larger error value. The main 
difference between these two methods is that fluorescence measurements were 
done at micro molar concentration (1 µM), the concentration had to be 
increased to 100 µM for ITC investigations as the method is less sensitive. 
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To investigate, whether pi-pi-interactions can explain the differences in 
stoichiometries, UV spectra of complex 2 at different concentrations were 
recorded (Figure 46). 
 
 
 
Figure 46. UV-spectra of complex 2 (HEPES buffer) at different 
concentrations. Concentrations were 100, 50, 10, 5, 1, 0.5 and 0.1 µM.  The red 
line indicates the UV-maximum and UV-minimum, respectively.  
 
 
The concentration dependent UV measurements did not indicate aggregate 
formation for compound 2 at the investigated concentrations. From UV 
measurements at different concentrations no clear indication on aggregate 
formation by pi-pi-stacking of the compounds could be derived. 
 146
Ti(IV)-salen complex 3. 
 
The complex 2 was investigated by a well-plate screening under physiological 
pH (7.4) in HEPES (2-(4-(2-Hydroxyethyl) - 1-piperazinyl)-ethansulfonic acid, 50 
mM, 25 °C) buffer solution. 
 
 
Figure 47. Fluorescence intensity change upon amino acid addition for Ti(IV)-
salophen complex using the well-plate technique (33 µM, 25 °C, λex = 330 nm, 
λem = 428 nm) of amino acids with functional groups in the side chain. 
 
 
Figure 47 shows that with Ti(IV)-salophen complex 3 no changes in 
fluorescence intensity are detectable upon addition of different amino acids with 
functionality in the side chain, such as histidine methylester, serine or aspartic 
acid. No affinity of complex 3 towards the added amino acids is observed.  
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Chiral salen complexes 4 and 5. 
 
Chiral Fe(III) complex 4 is known to interact with catechols and was previously 
used as a dioxygenase model.16,17 As this chiral salen complex is not 
fluorescent like its aromatic analogues, an indicator displacement assay was 
used to screen compound 4 for binding partners.  
 
 
 
Figure 48. Salophen (1, 2) and salen (4, 5) – screening for binding to 
pyrocatechol violet (PV, indicator) 
 
Pyrocatechol violet 12 is a catechol-type pH-sensitive dye. It is known that the 
green colour at neutral pH (7.4) changes to blue when the catechol interacts as 
a ligand with a metal complex.18 Figure 48 shows the PV response to the four 
different metal-salen complexes 1, 2, 4 and 5. As can be seen by the naked-
eye, only the chiral Fe(III)-salen binds to the indicator. All the other complexes 
do not interact with the catechol-type dye 12. 
PV + Ni-salen + Ni-salophen + Fe-salophen + Fe-salen 
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Figure 49. Pyrocatechol violet indicator 12.  Groups which are involved in the 
interaction with the complex are marked in red.  
 
 
 
Figure 50. Left: UV-titration of Fe(III)-salen 4 (500 µM, HEPES, 50 mM, 25 
°C, pH = 7.4) against pyrocatechol violet (50 µM, HEPES, 50 mM, 25°C, pH = 
7.4). The changes in absorbance intensity were plotted against equivalents of 
Fe(III)-salen. The inset shows the Job’s Plot analysis. Right: Changes in 
absorbance upon addition of aliquots of Fe(III)-salen. 
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The Fe(III)-salen complex 4 shows a binding stoichiometry of 1:1 and a rather 
high binding constant (lg K = 6.0) to pyrocatechol violet. The other tested salen 
complexes (1, 2 and 5) are not interacting with catechols. The observation that 
Ni(II)-complexes 1 and 2 are not binding to pyrocatechol violet is in accordance 
to literature reports stating that only Fe(III)-complexes binde to catechols.16,17 
However, it is surprising that the aromatic Fe(III)-salophen 1 is not binding.  
 
 
Figure 51. UV-spectra of the titration of a mixture of Fe(III)-salen (100 µM) 
and PV (100 µM, black line) against ATP (500 µM, 5 eq, blue line) and PPi (500 
µM, 5 eq, red line). 
 
Displacing the indicator by either ATP or PPi was not successful (Figure 51), 
which indicates a higher binding affinity for PV (lg K = 6.0) than for the tested 
analytes ATP and PPi,. The binding of ATP to complex 3 is therefore weaker 
than observed for the interaction of Fe(III)-salophen 1 with ATP (lg K = 7.7). 
 150
The determination of binding affinities by an indicator displacement method was 
not possible for the chiral Ni(II)-salen complex 5. Therefore, ITC measurements 
for this complex with HisOMe were performed, indicating an affinity in the lower 
millimolar range. This indicates that the binding affinity to HisOMe is 
significantly higher for the aromatic Ni(II)-salophen 2 than for its chiral 
counterpart 5. 
 
 
VI.3 Conclusion 
 
A small series of aromatic water-soluble salophen derivates containing Fe(III), 
Ni(II) and Ti(IV) were synthesized and tested for their ability to recognize amino 
acids.  
In the case of the Fe(III)-salophen derivative no binding could be observed for 
any of the tested amino acids, only for pyrophosphate (PPi) and adenosine-
triphosphate (ATP). Interaction of this complex with ATP results in a 1:1 
stoichiometry and a relatively high binding constant (lg K = 7.7). ITC 
measurements for this system could not be performed, due to the poor solubility 
of the complex in HEPES buffer. 
For Ni(II)-salophen derivative 2, interactions with histidine, histidine methylester 
and aspartic acid could be detected in the well-plate screening. We concluded 
from the screening results, that for sufficient binding the donor atoms of the 
amino acid should have a distance of five atoms and the amino acid should act 
as a bidentate ligand. The C-terminal part of the amino acid is not essential for 
the interaction. However, fluorescence measurements showed that the binding 
constant and the stoichiometry seems to be concentration dependant (different 
binding behaviour upon changing of added equivalents), whereas the ITC 
measurements do not confirm these observations. Aggregate formation by pi-pi-
interaction was excluded as the origin of the concentration dependency, 
because the UV spectra remain unchanged at different concentrations (Figure 
46).  
The salophen-derivative with Ti(IV) as the metal ion showed no affinity to any of 
the added analytes of this study.  
 151
Chiral salen derivatives with an aliphatic bridge between the aromatic moieties 
show much lower affinities to the same analytes than the non-chiral conjugated 
salophen-derivatives. However, the Fe(III)-salen complex binds catechols in the 
µM-range, which allows indicator displacement assays. ITC measurements are 
prohibited by the poor water solubility of the complex. 
Future studies of salophen complexes should focus on extended aromatic 
systems, like naphthalene, as the central aryl ring. This may prevent 
aggregation and will shift the excitation wavelength to longer wavelengths 
making the compounds more suitable for biological applications. Another issue 
to address is increasing the water solubility, which would then allow the use of 
ITC measurements to determine binding interactions. Presently, the compounds 
solubility limits their concentration in binding assays to 50-100 µM, which is not 
suitable for ITC measurements. 
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VI.4 Experimental Part 
 
1. Synthesis and characterization of compounds  
General. Thin layer chromatography (TLC) was performed on alumina plates 
coated with silica gel (Merck silica gel 60 F 254, layer thickness 0.2 mm). 
Column chromatography was performed on silica gel (70–230 mesh) from 
Merck. Starting materials were purchased from either Acros or Sigma-Aldrich 
and used without any further purification. Solvents were purchased from Aldrich 
and used without further purification except for dry THF, which was prepared by 
distillation from potassium. Complex 112, 211 and water-soluble salicylic 
aldehyde11 as well as chiral salen ligand 919 were prepared according to 
literature known procedures.  
 
Techniques. Melting points (MP) were determined with a Büchi SMP 20. IR-
spectra were recorded with a Bio-Rad FTS 2000 MX FT-IR spectrometer. NMR 
spectra were recorded on a Bruker Avance 300 (1H: 300.1 MHz, 13C: 75.5 
MHz, T = 300 K). The spectra are referenced against the NMR-solvent and 
chemical shifts are reported in ppm. MS-Spectra were determined on a Varian 
CH-5 (EI), a Finnigan MAT 95 (CI; FAB and FD) or a Finnigan MAT TSQ 7000 
(ESI). UV–Vis absorption spectroscopy was performed using a Cary 50 Bio 
spectrophotometer and fluorescence spectra were recorded using a Varian 
Cary Eclipse fluorescence spectrophotometer. 
 
 
 
Ti(IV)-salen 3. 
In a round-bottom flask aldehyde 8 (1 g, 4.3 mmol) and diamine 9 (0.2 g, 2.2 
mmol) were dissolved under a N2-atmosphere in dry THF (20 mL). With stirring 
NaOAc (0.8 g, 9.8 mmol) and 0.3 mL TiCl4 (3 mmol) were added and the 
mixture was stirred at reflux for 22 h. The orange precipitate was collected by 
vacuum filtration and washed with THF (20 mL). The solid was washed with 
EtOH (3 x 10 mL), petroleum ether (3 x 10 mL) and dried in vacuo. The product 
was obtained as an orange solid (0.8 g, 1.8 mmol, 83%).  
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Due to its very poor solubility in organic solvents and water no NMR spectrum 
could be recorded. 
ES-MS (H2O/CH3OH + 10 mM NH4OAc): m/z (%) = 557.8 [MH+Cl]- (100) , 
261.2 [M-2H+]2- (29), 522.3 [M-H+]- (11), FT-IR = 3364 (w), 3074 (w), 1577 (m), 
1146 (m), 1002 (w), 752 (s), 718 (s), 570 (s), 446 (s); MP > 300 °C. 
 
 
Ni(II)-salen 5.20 
Ligand 11 (0.5 g, 1 mmol) was dissolved in H2O (8 mL) and NaOAc (0.15 g, 
1.8 mmol, 2 eq). NiCl2 (0.2 g, 1 mmol, 1 eq) was added and the mixture was 
heated to reflux for 16 h. After this period the suspension was allowed to cool to 
room temperature and the precipitate was collected by centrifugation, washed 
two times with CH3CH2OH (13 mL) and tetrahydrofurane (13 mL). The product 
was obtained as an orange solid (0.52 g, 1 mmol, 96%). 
ES-MS (H2O/CH3OH + 10 mM NH4OAc): m/z (%) = 267.9 [M-2H+]2- (100), 
537.2 [M-H+]- (25); FT-IR = 3387 (m), 2930 (w), 1581 (s), 1468 (m), 1414 (m), 
1383 (w), 1179 (s), 1108 (s), 1034 (s), 932 (w), 829 (m), 746 (w), 688 (m), 614 
(s), 574 (m); MP > 300 °C. 
 
Fe(III)-salen 4.19 
Ligand 11 (0.5 g, 1 mmol) was dissolved in H2O (8 mL) and NaOAc (0.15 g, 
1.8 mmol, 2 eq). FeCl3 (0.3 g, 1 mmol, 1 eq) was added and the mixture was 
heated to reflux for 16 h. After this period the suspension was allowed to cool to 
room temperature, the precipitate was collected by centrifugation and washed 
two times with CH3CH2OH (13 mL) and tetrahydrofurane (13 mL). The product 
was obtained as a brown solid (0.55 g, 1 mmol, quant). 
ES-MS (H2O/CH3OH + 10 mM NH4OAc): m/z (%) = 268 [M-2H+]2- (7), 534.8 [M-
H+]- (4), 284.2 [M+O2]2- (25), 607.8 [MH2+2Cl]2- (10), 592.0 [MH2+CH3COO]- (5), 
296.4 [M+CH3COO]2- (100); FT-IR = 3504 (m), 2105 (w), 1601 (s), 1422 (w), 
1346 (w), 1269 (w), 1141 (s), 1013 (m), 825 (w), 790 (w), 585 (m); MP > 300 
°C. 
 154
Isothermal titration calorimetry (ITC) and fluorescence titration: 
 
 
Ni-salophen 2 vs. HisOMe: 
 
 
Figure 52. Left: Isothermal titration calorimetry (ITC) studies for the binding of 
complex 2 towards HisOMe. The top panel on the left shows the raw data, 
generated by titration of 1.43 mL of 0.1 mM 2 by 60 injections (5 µL each) of 
1.25 mM HisOMe. The area under each peak was integrated and plotted 
against the molar ratio HisOMe to 2 in the left bottom panel. The solid smooth 
line (left) is the best fit of the data according to the two-binding site model for 
the following stoichiometries (N1 and N2), association constants (Ka1 and Ka2), 
and enthalpic changes (∆H°1 and ∆H°2). The values of N1, N2, Ka1, Ka2, ∆H°1, 
∆H°2 were determined to be 1.0 ± 0, 0.4 ± 0.006, (7.4 ± 2.4) x 103  M-1, (1.27 ± 
0.1) x 105 M-1, 1.6 ± 0.1 kcal/mol, and -11 ± 0.03 kcal/mol, respectively. Upper 
right: fluorescence titration of Ni(II)-salophen complex 2 (1 µM) with 7 eq 
HisOMe 15 µM). The changes in fluorescence intensity were plotted  
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against equivalents of HisOMe. The inset shows the Job’s Plot analysis. Lower 
right: fluorescence titration of Ni(II)-salophen 2 (1 µM) with 1.4 eq HisOMe 
(5 µM). The changes in fluorescence were plotted against equivalents of 
HisOMe. The inset shows the Job’s plot analysis. 
 
Ni-salophen 2 vs. Aspartic acid: 
 
 
 
Figure 53. Left: fluorescence titration of Ni(II)-salophen complex 2 (1 µM) with 
6 eq aspartic acid (20 µM). The changes in fluorescence intensity were plotted 
against equivalents of aspartic acid. The inset shows Job’s Plot analysis. Right: 
fluorescence titration of Ni(II)-salophen complex 2 (1 µM) with 2.4 eq aspartic 
acid (5 µM). The changes in fluorescence intensity were plotted against 
equivalents of aspartic acid. The plot could not be fitted with HypNMR and 
Origin (Hill plot). The inset shows Job’s Plot analysis. 
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Results: 
 
Method  
HisOMe  
lg K (sal : analyte) 
 aspartic acid  
lg K (sal : analyte) 
3.9 (1:1) no fit possible  
1.4 eq 
5.1 (2:1) 2.4 eq no fit possible 
6.2 (1:1) 5.5 (1:1) fluorescence 
7 eq 
3.3 (1:2) 6 eq 2.7 (1:2) 
3.9±1.9 (1:1) none ITC 3 eq 
5.1± 0.2 (1:2) none none 
 
sal = Ni(II)-salophen; none = not measured; 
 
Table 6. Result of binding studies showing data from fluorescence titration 
and ITC. 
 
The obtained binding stoichiometries and binding constants for Ni(II)-salophen 
complex 2 are not conclusive due to the change in stoichiometry upon addition 
of various amounts of analyte. The data obtained from ITC measurements do 
not match with those obtained by fluorescence. While fluorescence 
measurements were done at micro molar concentration (1 µM) the 
concentration had to be increased to 100 µM for ITC investigations in order to 
get reasonable results. Different binding affinities may therefore result from 
concentration dependant aggregates. Ni(II)-salen aggregates were already 
mentioned (Figure 43). 
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VII. Summary 
 
Im ersten Kapitel wurde ein photoaktiver Inhibitor für die menschliche 
Carboanhydrase I synthetisiert. Dieser basiert auf eine Dithienylethen-Einheit 
und  enthält auf der einen Seite, einen Cu(II)-Komplex, der selektiv Imidazol der 
Hisitidinseitenketten erkennt. Auf der anderen Seite wurde eine Sulfonamid 
Einheit angebracht, die ein seit Jahrzehnten benutzter Hemmstoff für 
Carboanhydrasen ist. Es konnte gezeigt werden, dass durch licht-induzierte 
Konformationsänderungen des Inhibitors, die Inhibitorwirkung, sowie die 
Aktivität des Enzyms verändert werden kann. Wird der Inhibitor mit sichtbaren 
Licht (Wellenlängen größer als 420 nm) bestrahlt, wird er in seine aktivste Form 
überführt. In dieser Form ist die Aktivität des Enzyms ca. eine Zehnerpotenz 
geringer als wäre die geschlossene Form präsent. Somit konnte gezeigt 
werden, dass es mit Hilfe  photochromer Verbindungen biologische Reaktionen 
mit Licht zu beeinflussen. 
 
Im zweiten Kapitel wurden die im ersten Kapitel hergestellten Substanzen auf 
ihre Selektivität innerhalb der menschlichen Carboanhydrase-Familie getestet. 
Diese waren die Isoformen I, II, IX, XII und XIV. Dabei wurde herausgefunden, 
dass für die Isoform I die symmetrisch aufgebauen Inhibitoren am 
wirkungsvollsten waren (zwei Sulfonamid-Einheiten und zwei Cu(II)-ida 
Einheiten), diese aber auch nur in ihrer offen Form. Das Molekül mit zwei 
Sulfonamide Einheiten war auch für die Isoform II der beste Inhibitor, hier 
konnte jedoch kein Unterschied zwischen der offen und der geschlossenen 
Form beobachtet werden. Die Isoform IX wurde nur schwach von allen 
Verbindungen inhibiert, wohingegen alle Verbindungen die Isoformen XII und 
XIV gar nicht inhibieren konnten. 
 
Photoaktive Verbindung, die symmetrisch und flexibel mit Zn(II)-cyclen 
Einheiten verknüpft wurden, wurden im dritten Kapitel auf ihre Eigenschaft 
untersucht, die Erkennung von Phosphat-anionen reversibel zu verändern 
(schalten). Die Messungen wurden mit Hilfe eines Indicator Displacement 
Assays durchgeführt. Dabei wurde beobachet, dass der Unterschied zwischen 
dem offenen und geschlossenen Isomer nur ca. eine Zehnerpotenz beträgt. 
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Auch die Bindungsaggregate, die in Lösung gebildet werden, konnten nicht 
eindeutig indentifiziert werden. Schlussfolgernd kann man sagen, dass für eine 
solche Art der Anwendung, Moleküle benutzt werden müssen, die vollkommen 
starr sind und nur durch die licht-induzierten Konformationsänderungen des 
Schalters abhängig sind. 
 
Im vierten Kapitel wurde eine Klasse von Diarylethenen untersucht, die in der 
Literatur eher wenig Bedeutung findet: Di-indolylethene. Diese enthalten statt 
der Thiophen-Einheiten zwei Indol-Einheiten. Durch diese Veränderung wird die 
geschlossene Form dieses Moleküls thermisch reversibel, was für 
Anwendungen ein schlechtes Charakteristikum ist. Mit Hilfe geeigneter 
(literaturbekannten) Veränderungen, ist die Verbindung für eine gewisse Zeit 
(bis zu 48 h) thermisch stabil. Es wurde beobachtet, dass in der geschlossenen 
Form die Stickstoffatome der Indol-Einheit basisch werden. Protoniert man 
diese basischen Stickstoffe durch protische Säuren (HOAc, Ameisensäure und 
Phosphorsäure), was abhängig von der Säurestärke ist, wird wahrscheinlich 
eine elektrocyklische Rückreaktion zur offenen Form katalysiert (Diese Theorie 
von der Arbeitsgruppe Prof. Dr. M. Schütz zur Zeit durch Berechnungen 
geprüft). Die offene Form zeigt keine Reaktion auf Säuren. 
 
Im fünften Kapitel wurde untersucht, inwiefern Metall-salen Komplexe zur 
selektiven Erkennung von Aminosäuren, sowie von Phosphat-anionen 
verwendet werden kann. Dabei wurde gefunden, dass achirale Ni(II)-Komplexe 
selektiv terminales Histidin, sowie terminale Asparaginsäure bindet. Die Affinität 
zu Histidin ist dabei höher als zu Asparaginsäure. Achirale Fe-salen Komplexe 
binden selektiv nur Phosphat-anionen und innerhalb der getesten Verbindungen 
auch nur Pyrophosphat (PPi) und ATP (lg K = 7.7). Chirale Salen Komplexe 
haben um ein vielfaches geringere Affinitäten als die achiralen Komlexe, wobei 
chirale Fe-salen Komplexe mit einer hohen Affinität Catechole binden. Alles in 
allem, wurde durch diese Voruntersuchungen gezeigt, dass diese Moleküle 
Potenzial zur Erkennung von Aminosäuren und Phosphat-anionen haben. 
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VIII. Abbreviations 
 
A anion 
Asp aspartic acid 
aq aqueous 
Boc tert-Butoxycarbonyl 
Bu butyl 
tBuOH tert-butanol 
c concentration 
calc calculated 
CC column chromatography 
d days 
DCM dichloromethane 
DMAP 4-(dimethylamino) 
pyridine 
DMF dimethylformamide 
DMSO dimethyl sulfoxide 
EA elemental analysis 
EDTA
 ethylenediaminetetraac
etic acid disodium salt 
EE ethyl acetate 
EI electronic ionisation 
eq equivalents 
ESI electronic spray 
ionisation 
Et ethyl 
Et2O diethyl ether 
EtOAc ethyl acetate 
EtOH ethanol 
FAB fast atom bombardment 
fig figure 
Fl fluorescence 
h hour 
Hepes 4-(2-hydroxyethyl)-
piperazine-1-ethane 
sulfonic acid 
His histidine 
HOBt 1-Hydroxybenzotriazole 
HPLC high performance liquid 
chromatography 
HR high resolution 
IDA iminodiacetic acid 
IR infrared spectroscopy 
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J coupling constant 
K cation 
LC liquid chromatography 
Lys lysine 
M molecule 
Me methyl 
MeCN acetonitrile 
MeOH methanol 
min minutes 
Mp melting point 
MS mass spectroscopy 
MW molecular weight 
NEt3 triethyl amine 
NIR near infrared 
NMR nuclear magnetic 
resonance 
NTA nitrilotriacetic acid 
OAc acetate 
PE petrol ether 
Ph phenyl 
Phe phenylalanine 
Rf retention factor 
r.t. room temperature 
sat saturated 
Ser serine 
SN nucleophilic substitution 
TFA trifluoroacetic acid 
THF tetrahydrofurane 
TLC thin layer 
chromatography 
TMS trimethylsilyl 
TPP tetraphenyl porphyrin 
UV ultraviolet 
VIS visible 
x mole fraction 
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